v3.24.3
Document and Entity Information - shares
9 Months Ended
Sep. 30, 2024
Nov. 07, 2024
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2024  
Document Transition Report false  
Entity File Number 001-37949  
Entity Registrant Name Innovative Industrial Properties, Inc.  
Entity Incorporation, State or Country Code MD  
Entity Tax Identification Number 81-2963381  
Entity Address, Address Line One 1389 Center Drive, Suite 200  
Entity Address, City or Town Park City  
Entity Address, State or Province UT  
Entity Address, Postal Zip Code 84098  
City Area Code 858  
Local Phone Number 997-3332  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   28,331,833
Entity Central Index Key 0001677576  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q3  
Amendment Flag false  
Common Stock    
Title of 12(b) Security Common Stock, par value $0.001 per share  
Trading Symbol IIPR  
Security Exchange Name NYSE  
Series A Preferred Stock    
Title of 12(b) Security Series A Preferred Stock, par value $0.001 per share  
Trading Symbol IIPR-PA  
Security Exchange Name NYSE  
v3.24.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Real estate, at cost:    
Land $ 146,043 $ 142,524
Buildings and improvements 2,209,720 2,108,218
Construction in progress 59,998 117,773
Total real estate, at cost 2,415,761 2,368,515
Less accumulated depreciation (253,165) (202,692)
Net real estate held for investment 2,162,596 2,165,823
Construction Loan receivable 22,000 22,000
Cash and cash equivalents 147,128 140,249
Restricted cash   1,450
Investments 25,315 21,948
Right of use office lease asset 1,051 1,355
In-place lease intangible assets, net 7,600 8,245
Other assets, net 29,641 30,020
Total assets 2,395,331 2,391,090
Liabilities:    
Exchangeable Senior Notes, net   4,431
Notes due 2026, net 297,503 296,449
Building improvements and construction funding payable 9,204 9,591
Accounts payable and accrued expenses 14,961 11,406
Dividends payable 54,817 51,827
Rent received in advance and tenant security deposits 61,084 59,358
Other liabilities 11,225 5,056
Total liabilities 448,794 438,118
Commitments and contingencies (Notes 6 and 11)
Stockholders' equity:    
Preferred stock, par value $0.001 per share, 50,000,000 shares authorized: 9.00% Series A cumulative redeemable preferred stock, liquidation preference of $25.00 per share, 1,002,673 and 600,000 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively 23,632 14,009
Common stock, par value $0.001 per share, 50,000,000 shares authorized: 28,331,833 and 28,140,891 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively 28 28
Additional paid-in capital 2,119,798 2,095,789
Dividends in excess of earnings (196,921) (156,854)
Total stockholders' equity 1,946,537 1,952,972
Total liabilities and stockholders' equity $ 2,395,331 $ 2,391,090
v3.24.3
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Preferred stock, Par Value (in dollars per share) $ 0.001 $ 0.001
Preferred Stock, Shares Authorized 50,000,000 50,000,000
Common Stock, Par Value (in dollars per share) $ 0.001 $ 0.001
Common Stock, Shares Authorized 50,000,000 50,000,000
Common Stock, Shares Issued 28,331,833 28,140,891
Common Stock, Shares Outstanding 28,331,833 28,140,891
Series A Preferred Stock    
Preferred Stock, Dividend Rate, Percentage 9.00% 9.00%
Preferred Stock, Liquidation Preference Per Share $ 25.00 $ 25.00
Preferred Stock, Shares Issued 1,002,673 600,000
Preferred Stock, Shares Outstanding 1,002,673 600,000
v3.24.3
Condensed Consolidated Statements of Income - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenues:        
Rental (including tenant reimbursements) $ 76,052 $ 77,286 $ 230,219 $ 228,734
Other 474 540 1,554 1,616
Total revenues 76,526 77,826 231,773 230,350
Expenses:        
Property expenses 7,295 6,318 20,867 17,700
General and administrative expense 9,330 10,981 28,553 31,924
Depreciation and amortization expense 17,944 16,678 52,567 50,096
Total expenses 34,569 33,977 101,987 99,720
Gain (loss) on sale of real estate     (3,449)  
Income from operations 41,957 43,849 126,337 130,630
Interest income 2,685 2,075 8,435 6,625
Interest expense (4,427) (4,330) (13,136) (13,322)
Gain (loss) on exchange of Exchangeable Senior Notes       22
Net income 40,215 41,594 121,636 123,955
Preferred stock dividends (564) (338) (1,240) (1,014)
Net income attributable to common stockholders $ 39,651 $ 41,256 $ 120,396 $ 122,941
Net income attributable to common stockholders per share (Note 8):        
Basic (in dollars per share) $ 1.38 $ 1.46 $ 4.21 $ 4.36
Diluted (in dollars per share) $ 1.37 $ 1.45 $ 4.16 $ 4.32
Weighted-average shares outstanding:        
Basic (in shares) 28,254,565 27,983,004 28,216,946 27,971,544
Diluted (in shares) 28,579,687 28,265,605 28,548,050 28,248,054
v3.24.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Series A Preferred Stock
Preferred Stock
Common Stock
Additional Paid-In-Capital
Dividends in Excess of Earnings
Total
Balances at beginning of period at Dec. 31, 2022 $ 14,009 $ 28 $ 2,065,248 $ (117,392) $ 1,961,893
Balances at beginning of period (in shares) at Dec. 31, 2022 600,000 27,972,830      
Net Income (Loss)       123,955 123,955
Issuance of unvested restricted stock, net of forfeitures     (568)   (568)
Issuance of unvested restricted stock, net of forfeitures (in shares)   34,800      
Exchange of Exchangeable Senior Notes     1,964   1,964
Exchange of Exchangeable Senior Notes (in shares)   32,200      
Preferred stock dividend       (1,014) (1,014)
Common stock dividend       (152,208) (152,208)
Stock-based compensation     14,647   14,647
Balances at end of period at Sep. 30, 2023 $ 14,009 $ 28 2,081,291 (146,659) 1,948,669
Balances at end of period (in shares) at Sep. 30, 2023 600,000 28,039,830      
Balances at beginning of period at Jun. 30, 2023 $ 14,009 $ 28 2,076,357 (137,174) 1,953,220
Balances at beginning of period (in shares) at Jun. 30, 2023 600,000 28,040,054      
Net Income (Loss)       41,594 41,594
Issuance of unvested restricted stock, net of forfeitures (in shares)   (224)      
Preferred stock dividend       (338) (338)
Common stock dividend       (50,741) (50,741)
Stock-based compensation     4,934   4,934
Balances at end of period at Sep. 30, 2023 $ 14,009 $ 28 2,081,291 (146,659) 1,948,669
Balances at end of period (in shares) at Sep. 30, 2023 600,000 28,039,830      
Balances at beginning of period at Dec. 31, 2023 $ 14,009 $ 28 2,095,789 (156,854) 1,952,972
Balances at beginning of period (in shares) at Dec. 31, 2023 600,000 28,140,891      
Net Income (Loss)       121,636 121,636
Issuance of unvested restricted stock, net of forfeitures     (750)   (750)
Issuance of unvested restricted stock, net of forfeitures (in shares)   39,310      
Net proceeds from sale of preferred stock $ 9,623       9,623
Net proceeds from sale of preferred stock (in shares) 402,673        
Exchange of Exchangeable Senior Notes (in shares)   28,408      
Net proceeds from sale of common stock     11,757   11,757
Net proceeds from sale of common stock (in shares)   123,224      
Preferred stock dividend       (1,240) (1,240)
Common stock dividend       (160,463) (160,463)
Stock-based compensation     13,002   13,002
Balances at end of period at Sep. 30, 2024 $ 23,632 $ 28 2,119,798 (196,921) 1,946,537
Balances at end of period (in shares) at Sep. 30, 2024 1,002,673 28,331,833      
Balances at beginning of period at Jun. 30, 2024 $ 14,009 $ 28 2,115,482 (182,319) 1,947,200
Balances at beginning of period (in shares) at Jun. 30, 2024 600,000 28,331,833      
Net Income (Loss)       40,215 40,215
Net proceeds from sale of preferred stock $ 9,623       9,623
Net proceeds from sale of preferred stock (in shares) 402,673        
Preferred stock dividend       (564) (564)
Common stock dividend       (54,253) (54,253)
Stock-based compensation     4,316   4,316
Balances at end of period at Sep. 30, 2024 $ 23,632 $ 28 $ 2,119,798 $ (196,921) $ 1,946,537
Balances at end of period (in shares) at Sep. 30, 2024 1,002,673 28,331,833      
v3.24.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities    
Net income $ 121,636 $ 123,955
Adjustments to reconcile net income to net cash provided by (used in) operating activities    
Depreciation and amortization 52,567 50,096
Loss (gain) on exchange of Exchangeable Senior Notes   (22)
Loss (gain) on sale of real estate 3,449  
Other non-cash adjustments 79 83
Stock-based compensation 13,002 14,647
Amortization of discounts on investments (504) (2,894)
Amortization of debt discount and issuance costs 1,214 1,021
Changes in assets and liabilities    
Other assets, net (2,800) (2,905)
Accounts payable, accrued expenses and other liabilities 10,271 5,077
Rent received in advance and tenant security deposits 1,726 404
Net cash provided by (used in) operating activities 200,640 189,462
Cash flows from investing activities    
Purchases of investments in real estate (13,026) (34,906)
Proceeds from sale of real estate asset 9,100  
Funding of draws for improvements and construction (45,642) (129,502)
Funding of Construction Loan and other investments   (3,535)
Purchases of short-term investments (45,110) (91,772)
Maturities of short-term investments 42,247 253,716
Net cash provided by (used in) investing activities (52,431) (5,999)
Cash flows from financing activities    
Issuance of common stock, net of offering costs 11,757  
Issuance of preferred stock, net of offering costs 9,623  
Principal payment on Exchangeable Senior Notes (4,436)  
Payment of deferred financing costs (261)  
Dividends paid to common stockholders (157,699) (151,969)
Dividends paid to preferred stockholders (1,014) (1,014)
Taxes paid related to net share settlement of equity awards (750) (568)
Net cash provided by (used in) financing activities (142,780) (153,551)
Net increase (decrease) in cash, cash equivalents and restricted cash 5,429 29,912
Cash, cash equivalents and restricted cash, beginning of period 141,699 88,572
Cash, cash equivalents and restricted cash, end of period 147,128 118,484
Supplemental disclosure of cash flow information:    
Cash paid during the period for interest, net of interest capitalized 7,806 8,253
Supplemental disclosure of non-cash investing and financing activities:    
Accrual for current-period additions to real estate 8,574 10,520
Deposits applied for acquisitions   250
Accrual for common and preferred stock dividends declared 54,817 51,079
Reclassification from other assets to real estate held for investment $ 3,152  
Exchange of Exchangeable Senior Notes for common stock   $ 1,964
v3.24.3
Organization
9 Months Ended
Sep. 30, 2024
Organization  
Organization

1. Organization

As used herein, the terms “we”, “us”, “our” or the “Company” refer to Innovative Industrial Properties, Inc., a Maryland corporation, and any of our subsidiaries, including IIP Operating Partnership, LP, a Delaware limited partnership (our “Operating Partnership”).

We are an internally-managed real estate investment trust (“REIT”) focused on the acquisition, ownership and management of specialized industrial properties leased to experienced, state-licensed operators for their regulated cannabis facilities. We have acquired and intend to continue to acquire our properties through sale-leaseback transactions and third-party purchases. We have leased and expect to continue to lease our properties on a triple-net lease basis, where the tenant is responsible for all aspects of and costs related to the property and its operation during the lease term, including structural repairs, maintenance, real estate taxes and insurance.

We were incorporated in Maryland on June 15, 2016. We conduct our business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which our properties are owned by our Operating Partnership, directly or through subsidiaries. We are the sole general partner of our Operating Partnership and own, directly or through subsidiaries, 100% of the limited partnership interests in our Operating Partnership.

v3.24.3
Summary of Significant Accounting Policies and Procedures and Recent Accounting Pronouncements
9 Months Ended
Sep. 30, 2024
Summary of Significant Accounting Policies and Procedures and Recent Accounting Pronouncements  
Summary of Significant Accounting Policies and Procedures and Recent Accounting Pronouncements

2. Summary of Significant Accounting Policies and Procedures and Recent Accounting Pronouncements

Basis of Presentation. The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements.

This interim financial information should be read in conjunction with the audited consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. Any references to square footage or occupancy percentage, and any amounts derived from these values in these notes to the condensed consolidated financial statements, are outside the scope of our independent registered public accounting firm’s review.

Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. This interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, 2024.

Federal Income Taxes. We believe that we have operated our business so as to qualify to be taxed as a REIT for U.S. federal income tax purposes. Under the REIT operating structure, we are permitted to deduct dividends paid to our stockholders in determining our taxable income. Assuming our dividends equal or exceed our taxable net income, we generally will not be required to pay federal corporate income taxes on such income. The income taxes recorded on our condensed consolidated statements of income represent amounts paid for city and state income and franchise taxes and are included in general and administrative expenses in the accompanying condensed consolidated statements of income.

Use of Estimates. The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make a number of estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the condensed consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Actual results may differ materially from these estimates and assumptions. The most significant estimates and assumptions made include the determination of lease accounting and fair value of acquisition of real estate properties.

Reportable Segment. We are engaged in the business of providing real estate for the regulated cannabis industry. Our properties are similar in that they are leased to the state-licensed operators on a long-term triple-net basis, consist of improvements that are reusable and have similar economic characteristics. Our chief operating decision maker reviews financial information for our entire consolidated operations when making decisions related to assessing our operating performance. We have aggregated the properties into one reportable segment as the properties share similar long-term economic characteristics and have other similarities, including the fact that they are operated using consistent business strategies. The financial information disclosed herein represents all of the financial information related to our one reportable segment.

Acquisition of Real Estate Properties. Our investment in real estate is recorded at historical cost, less accumulated depreciation. Upon acquisition of a property, the tangible and intangible assets acquired and liabilities assumed are initially measured based upon their relative fair values. We estimate the fair value of land by reviewing comparable sales within the same submarket and/or region. We estimate the fair value of buildings and improvements as if the property was vacant, taking into consideration current replacement costs and other relevant market rate information and may engage third-party valuation specialists. Acquisition costs are capitalized as incurred. All of our acquisitions to date were recorded as asset acquisitions.

The fair value of acquired in-place leases is derived based on our assessment of estimated lost revenue and costs incurred for the period required to lease the “assumed vacant” property to the occupancy level when purchased. The amounts recorded for acquired in-place leases are reflected as in-place lease intangible assets, net on our condensed consolidated balance sheets and are amortized on a straight-line basis as a component of depreciation and amortization expense over the remaining term of the applicable leases.

The fair value of the above-market component of an acquired in-place operating lease is based upon the present value (calculated using a market discount rate) of the difference between (i) the contractual rents to be paid pursuant to the lease over its remaining non-cancellable lease term and (ii) our estimate of the rents that would be paid using fair market rental rates and rent escalations at the date of acquisition measured over the remaining non-cancellable term of the lease. The amount recorded for one above-market operating lease is included in other assets, net on our condensed consolidated balance sheets and is amortized on a straight-line basis as a reduction of rental revenues over the remaining term of the applicable lease.

Certain acquisitions of real estate did not satisfy the requirements for sale-leaseback accounting and therefore as of September 30, 2024 and December 31, 2023, acquisitions of $16.8 million and $20.0 million, respectively have been recognized as notes receivable and are included in other assets, net on our condensed consolidated balance sheets. During the three months ended September 30, 2024, a $3.2 million acquisition of real estate which previously did not satisfy the requirements for sale-leaseback accounting was reclassified to real estate held for investment as the requirements for sale-leaseback accounting were satisfied.

Sale of Real Estate. When a real estate asset is sold, we evaluate the provisions of Accounting Standards Codification (“ASC”) 610-20, Gains and Losses from the Derecognition of Nonfinancial Assets (“ASC 610-20”) to determine whether the asset is within the scope of ASC 610-20, including an evaluation of whether the asset being sold is a nonfinancial asset and whether the buyer has gained control of an asset within the scope of ASC 610-20. In assessing whether the buyer has gained control of the asset, we must determine whether the contract criteria in ASC 606, Revenue from Contracts with Customers (Topic 606) have been met, including 1) the parties to the contract have approved the contract and the contract has commercial substance, 2) we can identify each party’s rights regarding the asset to be transferred, 3) we can identify the payment terms for the asset to be transferred, and 4) it is probable that we will collect substantially all of the consideration to which we will be entitled in exchange for the asset to be transferred. If all of the contract criteria have been met, the carrying amount of the applicable asset is derecognized with a corresponding gain or loss from the sale recognized in our consolidated statements of income. If the contract criteria are not all met, the asset transferred is not derecognized and we continue to report the asset in our condensed consolidated balance sheet. See Note 6 “Investments in Real Estate - Property Disposition” for further information.

Cost Capitalization and Depreciation. We capitalize costs (including interest) associated with development and redevelopment activities and improvements when we are considered to be the accounting owner of the resulting assets. The development and redevelopment activities may be funded by us pursuant to the lease. We are generally considered the accounting owner for such improvements that are attached to or built into the premises, which are required under the lease to be surrendered to us upon the expiration or earlier termination of the lease. Typically, such improvements include, but are not limited to, ground up development, and enhanced HVAC, plumbing, electrical and other building systems.

Amounts capitalized are depreciated on a straight-line basis over the estimated useful lives determined by management. We depreciate buildings and improvements based on our evaluation of the estimated useful life of each specific asset, not to exceed 40 years. For the three months ended September 30, 2024 and 2023, we recognized depreciation expense of $17.7 million and $16.5 million, respectively, and for the nine months ended September 30, 2024 and 2023, we recognized depreciation expense of $51.9 million and $49.5 million, respectively. Depreciation expense relating to our real estate held for investment is included in depreciation

and amortization expense in our condensed consolidated statements of income. We depreciate office equipment and furniture and fixtures on a straight-line basis over the estimated useful lives ranging from three to seven years. We depreciate the leasehold improvements at our corporate office on a straight-line basis over the shorter of the estimated useful lives or the remaining lease term. Depreciation expense relating to our corporate assets is included in general and administrative expense in our condensed consolidated statements of income.

Determining whether expenditures meet the criteria for capitalization and the assignment of depreciable lives requires management to exercise significant judgment. Project costs that are clearly associated with the acquisition and development or redevelopment of a real estate project, for which we are the accounting owner, are capitalized as a cost of that project. Expenditures that meet one or more of the following criteria generally qualify for capitalization:

the expenditure provides benefit in future periods; and
the expenditure extends the useful life of the asset beyond our original estimates.

We define redevelopment properties as existing properties for which we expect to spend significant development and construction costs that are not reimbursements to tenants for improvements at the properties. When existing properties are determined to be redevelopment properties, the net carrying value of the buildings and improvements are transferred to construction in progress while the redevelopment activities are in process. Costs capitalized to construction in progress related to redevelopment properties are transferred to buildings and improvements at historical cost of the properties as the redevelopment project or phases of projects are placed in service.

Provision for Impairment. On a quarterly basis, we review current activities and changes in the business conditions of all of our properties prior to and subsequent to the end of each quarter to determine the existence of any triggering events or impairment indicators requiring an impairment analysis. If triggering events or impairment indicators are identified, we review an estimate of the future undiscounted cash flows for the properties.

Long-lived assets are individually evaluated for impairment when conditions exist that may indicate that the carrying amount of a long-lived asset may not be recoverable. The carrying amount of a long-lived asset to be held and used is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. Impairment indicators or triggering events for long-lived assets to be held and used are assessed by project and include significant fluctuations in estimated net operating income, occupancy changes, significant near-term lease expirations, current and historical operating and/or cash flow losses, construction costs, estimated completion dates, rental rates, and other market factors. We assess the expected undiscounted cash flows based upon numerous factors, including, but not limited to, construction costs, available market information, current and historical operating results, known trends, current market/economic conditions that may affect the property, and our assumptions about the use of the asset, including, if necessary, a probability-weighted approach if multiple outcomes are under consideration. Upon determination that an impairment has occurred, a write-down is recognized to reduce the carrying amount to its estimated fair value. We may adjust depreciation of properties that are expected to be disposed of or redeveloped prior to the end of their useful lives. No impairment losses were recognized during the three and nine months ended September 30, 2024 and 2023.

Revenue Recognition. Our leases are triple-net leases, an arrangement under which the tenant maintains the property while paying us rent. We recognize revenue for each of the leases at our properties that are classified as operating leases on a cash basis due to the uncertain regulatory environment in the United States pertaining to the regulated cannabis industry, the limited operating history of certain tenants and the resulting uncertainty of collectability of lease payments from each tenant over the duration of the lease term. Additionally, for operating leases, contractually obligated reimbursements from tenants for recoverable real estate taxes, insurance and operating expenses are included in rental revenues in the period when such costs are incurred and reimbursed by the tenants. Contractually obligated real estate taxes that are paid directly by the tenant to the tax authorities are not reflected in our condensed consolidated financial statements.

For the three and nine months ended September 30, 2024, rental revenue recognized included the application of $1.4 million and $2.0 million of security deposits for rent, respectively. For the three and nine months ended September 30, 2023, rental revenue recognized included the application of $2.2 million and $8.0 million of security deposits for rent, respectively.

Construction Loan. We executed a construction loan agreement with a developer, pursuant to which we agreed to lend up to $23.0 million for the development of a regulated cannabis cultivation and processing facility in California (the “Construction Loan”). We have an option to purchase the property, and may execute a negotiated lease with an affiliate of the developer or with another third party, if we determine to exercise our purchase option. The Construction Loan matures on December 31, 2024. As of both September

30, 2024 and December 31, 2023, we had funded $22.0 million of the $23.0 million total commitment. Interest income on the Construction Loan is recognized on a cash basis.

Cash and Cash Equivalents. We consider all highly-liquid investments with original maturities of 90 days or less to be cash equivalents, which is comprised of short-term money market funds, obligations of the U.S. government and certificates of deposit with an original maturity at the time of purchase of less than or equal to 90 days.

Restricted Cash. Restricted cash relates to cash held in escrow accounts for future draws for improvements for tenants in accordance with certain lease agreements.

Investments. Investments consist of short-term obligations of the U.S. government and certificates of deposit with an original maturity at the time of purchase of greater than 90 days. Investments in obligations of the U.S. government are classified as held-to-maturity and stated at amortized cost. Investments in certificates of deposit are classified as held-to-maturity and stated at cost.

Deferred Financing Costs. The deferred financing costs relating to our Notes due 2026 are included as a reduction in the net book value of the related liability on our condensed consolidated balance sheet. These costs are amortized as non-cash interest expense using the effective interest method over the life of the related obligations. Deferred financing costs relating to our Revolving Credit Facility are included in other assets, net in our condensed consolidated balance sheets. These costs are being amortized on a straight-line basis and recognized as non-cash interest expense over the remaining term of the Revolving Credit Facility.

Stock-Based Compensation. Stock-based compensation for equity awards is based on the grant date fair value of the equity awards and is recognized over the requisite service or performance period. If awards are forfeited prior to vesting, we reverse any previously recognized expense related to such awards in the period during which the forfeiture occurs and reclassify any non-forfeitable dividends and dividend equivalents previously paid on these awards from retained earnings to compensation expense. Forfeitures are recognized as incurred. Certain equity awards are subject to vesting based upon the satisfaction of various market conditions. Forfeiture of share awards with market-based restrictions does not result in a reversal of previously recognized share-based compensation expense.

Lease Accounting. We account for our leases under ASC 842, Leases, and have elected the practical expedient not to separate certain non-lease components from the lease component if the timing and pattern of transfer are the same for the non-lease component and associated lease component, and the lease component would be classified as an operating lease if accounted for separately. We also elected the short-term lease exception for lessees for leases that are less than 12 months. As lessee, we recognized a liability to account for our future obligations and a corresponding right-of-use asset related to our corporate office lease, which ends in January 2027 and contains annual escalations. We measured the lease liability based on the present value of the future lease payments (excluding the extension option that we are not reasonably certain to exercise), discounted using the estimated incremental borrowing rates of 7.25% and 5.5%, which were the interest rates that we estimated we would have to pay to borrow on a collateralized basis over a similar term for an amount equal to the lease payments at initial commencement in December 2019 and upon an amendment in November 2021, respectively. Subsequently, the lease liability is accreted by applying a discount rate established at the lease commencement date to the lease liability balance as of the beginning of the period and is reduced by the payments made during the period.

The right-of-use asset is measured based on the corresponding lease liability. We did not incur any initial direct leasing costs or exchange any other consideration with the landlord prior to the commencement of the lease. Subsequently, the right-of-use asset is amortized on a straight-line basis during the lease term. In each of the three and nine months ended September 30, 2024 and 2023, we recognized office lease expense of $0.1 million and $0.4 million, respectively, which is included in general and administrative expenses in our condensed consolidated statements of income. In each of the nine months ended September 30, 2024 and 2023, amounts paid and classified as operating activities in our condensed consolidated statements of cash flows for the office lease were $0.4 million.

As lessor, for each of our real estate transactions involving the leaseback of the related property to the seller or affiliates of the seller, we determine whether these transactions qualify as sale and leaseback transactions under the accounting guidance. For these transactions, we consider various inputs and assumptions including, but not necessarily limited to, lease terms, renewal options, discount rates, and other rights and provisions in the purchase and sale agreement, lease and other documentation to determine whether control has been transferred to the Company or remains with the lessee. A transaction involving a sale leaseback will be treated as a purchase of a real estate property if it is considered to transfer control of the underlying asset from the lessee. A lease will be classified as direct-financing if risks and rewards are conveyed without the transfer of control and will be classified as a sales-type lease if control of the underlying asset is transferred to the lessee. Otherwise, the lease is treated as an operating lease. These criteria also include estimates and assumptions regarding the fair value of the leased facilities, minimum lease payments, the economic useful

life of the facilities, the existence of a purchase option, and certain other terms in the lease agreements. The lease accounting guidance requires accounting for a transaction as a financing in a sale leaseback when the seller-lessee is provided an option to purchase the property from the landlord at the tenant’s option. Substantially all of our leases are classified as operating leases.

Lease amendments are evaluated to determine if the modification grants the lessee an additional right-of-use not included in the original lease and if the lease payments increase commensurate with the standalone price of the additional right-of-use, adjusted for the circumstances of the particular contract. If both conditions are present, the lease amendment is accounted for as a new lease that is separate from the original lease. In January 2024, the lease modifications for two of our leases to extend the initial term of each lease changed the lease classification from operating lease to sales-type lease that did not satisfy all the criteria for recognition as a completed sale. Accordingly, we have not derecognized the underlying assets and all lease payments received, as well as any future lease payments, will be recognized as a deposit liability and will be included in other liabilities on our condensed consolidated balance sheet until certain criteria are met. As of September 30, 2024, we have received lease payments of $4.4 million that have been included in other liabilities on our condensed consolidated balance sheet. The underlying assets’ land and building and improvements had a gross carrying value of $4.1 million and $28.9 million, respectively, and accumulated depreciation of $3.3 million as of September 30, 2024.

Our leases generally contain options to extend the lease terms at the prevailing market rate or at the expiring rental rate at the time of expiration. Certain of our leases provide the lessee with a right of first refusal or right of first offer in the event we market the leased property for sale.

Recent Accounting Pronouncements. In November 2023, the Financial Accounting Standards Board issued Accounting Standards Update 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”). The amendments in ASU 2023-07 improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses, measures of segment profit and loss, and disclosures of how the chief operating decision maker uses the reported measure(s) of a segment’s profit or loss in assessing segment performance and deciding how to allocate resources. The amendments are effective for all public entities that are required to report segment information for fiscal years beginning after December 15, 2023 and interim periods beginning after December 15, 2024. ASU 2023-07 also requires a public entity that has a single reportable segment to provide all the disclosures required by the amendments in ASU 2023-07 and all existing segment disclosures in Topic 280. Early adoption is permitted. The amendments should be applied retrospectively to all prior periods presented. The Company is currently evaluating the potential impact that this standard will have on its condensed consolidated financial statements and related disclosures.

Concentration of Credit Risk. As of September 30, 2024, we owned 108 properties located in 19 states and leased to 30 tenants (excluding three non-cannabis tenants at two of our properties). The ability of any of our tenants to honor the terms of their leases is dependent upon the economic, regulatory, competition, natural and social factors affecting the community in which that tenant operates.

The following table sets forth the five tenants in our portfolio that represented the largest percentage of our total rental revenues for the three and nine months ended September 30, 2024 and 2023, including tenant reimbursements:

For the Three Months Ended

 

September 30, 2024

Percentage of

    

Number of 

    

 Rental 

 

    

Leases

    

Revenue

PharmaCann Inc. ("PharmaCann")

 

11

17

%

Ascend Wellness Holdings, Inc. ("Ascend")

 

4

11

%

Green Thumb Industries, Inc. ("Green Thumb")

 

3

8

%

Curaleaf Holdings, Inc. ("Curaleaf")

 

8

7

%

Trulieve Cannabis Corp. ("Trulieve")

6

7

%

For the Nine Months Ended

 

September 30, 2024

Percentage of

    

Number of 

    

 Rental 

 

    

Leases

    

Revenue

PharmaCann

 

11

17

%

Ascend

4

11

%

Green Thumb

 

3

8

%

Holistic Industries Inc.

 

5

8

%

Curaleaf

8

7

%

For the Three Months Ended

September 30, 2023

    

    

Percentage of 

    

 

Number of 

 

Rental 

 

    

Leases

    

Revenue

    

PharmaCann

11

15

%

Ascend

4

10

%

Green Thumb

3

8

%

Curaleaf

8

7

%

Trulieve

6

7

%

For the Nine Months Ended

 

September 30, 2023

Percentage of

    

Number of 

    

 Rental 

 

    

Leases

    

Revenue

PharmaCann

 

11

15

%

Ascend

4

10

%

Green Thumb

 

3

8

%

Curaleaf

8

7

%

SH Parent, Inc. ("Parallel")(1)

 

4

7

%

(1)We regained possession of two properties previously leased to Parallel in Texas and Pennsylvania in 2023.

In each of the tables above, these leases include leases with affiliates of each entity, for which the entity has provided a corporate guaranty.

As of September 30, 2024 and December 31, 2023, our largest property was located in New York and accounted for 5.5% and 5.4%, respectively, of our net real estate held for investment. No other properties accounted for more than 5% of our net real estate held for investment as of September 30, 2024 and December 31, 2023.

We have deposited cash with financial institutions that are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. As of September 30, 2024, we had cash accounts in excess of FDIC insured limits. We have not experienced any losses in such accounts.

v3.24.3
Common Stock
9 Months Ended
Sep. 30, 2024
Common Stock.  
Common Stock

3. Common Stock

As of September 30, 2024, the Company was authorized to issue up to 50,000,000 shares of common stock, par value $0.001 per share, and there were 28,331,833 shares of common stock issued and outstanding.

In May 2024, we terminated the previously existing “at-the-market” offering program (the “Prior ATM Program”) and entered into new equity distribution agreements with four sales agents, pursuant to which we may offer and sell from time to time through an “at-the-market” offering program (the “ATM Program”), including on a forward basis, shares of our common stock and 9.00% Series A Cumulative Redeemable Preferred Stock, $0.001 par value per share (the “Series A Preferred Stock”), up to an aggregate offering price of $500.0 million. See Note 4 “Preferred Stock” for information regarding the sale of Series A Preferred Stock under the ATM Program.

During the nine months ended September 30, 2024, we sold 123,224 shares of our common stock pursuant to the Prior ATM Program for net proceeds of $11.8 million. No shares of common stock were issued pursuant to the Prior ATM Program during the nine months ended September 30, 2023.

During the nine months ended September 30, 2024, we issued 28,408 shares of our common stock related to the exchange premium upon exchange by holders of $4.3 million of outstanding principal amount of our 3.75% Exchangeable Senior Notes due 2024 (the “Exchangeable Senior Notes”).

During the nine months ended September 30, 2023, we issued 32,200 shares of our common stock upon exchange by holders of $2.0 million of outstanding principal amount of our Exchangeable Senior Notes.

v3.24.3
Preferred Stock
9 Months Ended
Sep. 30, 2024
Preferred Stock.  
Preferred Stock

4. Preferred Stock

As of September 30, 2024, the Company was authorized to issue up to 50,000,000 shares of preferred stock, par value $0.001 per share, and there were 1,002,673 shares issued and outstanding of Series A Preferred Stock. The Company may, at its option, redeem the Series A Preferred Stock, in whole or in part, at any time or from time to time, for cash at a redemption price of $25.00 per share, plus all accrued and unpaid dividends on such Series A Preferred Stock up to, but excluding, the redemption date. Holders of the Series A Preferred Stock generally have no voting rights except for limited voting rights if the Company fails to pay dividends for six or more quarterly periods (whether or not consecutive) and in certain other circumstances.

During the nine months ended September 30, 2024, we sold 402,673 shares of our Series A Preferred Stock pursuant to the ATM Program for net proceeds of $9.6 million.

v3.24.3
Dividends
9 Months Ended
Sep. 30, 2024
Dividends  
Dividends

5. Dividends

The following table describes the dividends declared by the Company during the nine months ended September 30, 2024:

    

    

Amount

    

    

Dividend

    

Dividend

Declaration Date

Security Class

Per Share

Period Covered

Paid Date

Amount

 

(In thousands)

March 15, 2024

Common stock

$

1.82

January 1, 2024 to March 31, 2024

April 15, 2024

$

51,957

March 15, 2024

Series A preferred stock

$

0.5625

January 15, 2024 to April 14, 2024

April 15, 2024

$

338

June 14, 2024

Common stock

$

1.90

April 1, 2024 to June 30, 2024

July 15, 2024

$

54,253

June 14, 2024

Series A preferred stock

$

0.5625

April 15, 2024 to July 14, 2024

July 15, 2024

$

338

September 13, 2024

Common stock

$

1.90

July 1, 2024 to September 30, 2024

October 15, 2024

$

54,253

September 13, 2024

Series A preferred stock

$

0.5625

July 15, 2024 to October 14, 2024

October 15, 2024

$

564

v3.24.3
Investments in Real Estate
9 Months Ended
Sep. 30, 2024
Investments in Real Estate  
Investments in Real Estate

6. Investments in Real Estate

Acquisitions

The Company made the following acquisition during the nine months ended September 30, 2024 (dollars in thousands):

Rentable 

 Square

 Purchase

Transaction

Property

    

Market

    

Closing Date

    

Feet(1)

    

 Price

    

 Costs

    

Total

Ocala

 

Florida

June 7, 2024

 

145,000

$

13,000

$

26

$

13,026

(2)

Total

 

145,000

$

13,000

$

26

$

13,026

(3)

(1)Includes expected rentable square feet at completion of construction at the property.
(2)The tenant is expected to complete improvements at the property, for which we agreed to provide funding of up to $30.0 million.
(3)$2.1 million was allocated to land and $10.9 million was allocated to building and improvements.

Acquired In-Place Lease Intangible Assets

In-place lease intangible assets and related accumulated amortization as of September 30, 2024 and December 31, 2023 is as follows (in thousands):

    

September 30, 2024

    

December 31, 2023

In-place lease intangible assets

$

9,979

$

9,979

Accumulated amortization

 

 

(2,379)

 

(1,734)

In-place lease intangible assets, net

$

7,600

$

8,245

Amortization of in-place lease intangible assets classified in depreciation and amortization expense in our condensed consolidated statements of income was $0.2 million in each of the three months ended September 30, 2024 and 2023, and $0.6 million in each of the nine months ended September 30, 2024 and 2023. The weighted-average remaining amortization period of the acquired in-place leases was 9.0 years, and the estimated annual amortization of the value of the acquired in-place leases as of September 30, 2024 is as follows (in thousands):

Year

    

Amount

2024 (three months ending December 31)

$

215

2025

 

860

2026

 

860

2027

 

860

2028

860

Thereafter

 

3,945

Total

$

7,600

Above-Market Lease

The above-market lease and related accumulated amortization included in other assets, net on our condensed consolidated balance sheets as of September 30, 2024 and December 31, 2023 is as follows (in thousands):

    

September 30, 2024

    

December 31, 2023

Above-market lease

$

1,054

$

1,054

Accumulated amortization

 

 

(256)

 

(187)

Above-market lease, net

$

798

$

867

The above-market lease is amortized on a straight-line basis as a reduction to rental revenues over the remaining lease term of 8.7 years. In each of the three and nine months ended September 30, 2024 and 2023, the amortization of the above-market lease was $23,000 and $69,000, respectively.

Lease Amendments

In January 2024, we entered into lease amendments with subsidiaries of 4Front Ventures Corp. (“4Front”) at the four properties we lease to them in Illinois, Massachusetts and Washington, extending the term of each lease. The Illinois property, which is under development, has experienced significant delays in construction, primarily relating to completion of required utilities enhancements, which has resulted in an extended delay of the estimated completion of the project. As a result, we amended the Illinois lease to reduce base rent owing for the nine months ending September 30, 2024, defer the payback of the security deposit applicable to the lease (with the security deposit being subject to future pro-rata monthly payback), and increase the base rent for the remainder of the term commencing November 1, 2024.

In February 2024, we amended our lease and development agreement with PharmaCann at one of our New York properties, increasing the construction funding commitment by $16.0 million, which also resulted in a corresponding adjustment to the base rent for the lease at the property. We also amended the lease to extend the term.

In April 2024, we amended our lease with a subsidiary of Battle Green Holdings LLC at one of our Ohio properties to provide an additional improvement allowance of $4.5 million, which also resulted in a corresponding adjustment to the base rent for the lease at the property.

In April 2024, we amended the lease with a subsidiary of 4Front at one of our Illinois properties to provide an additional improvement allowance of $1.6 million, which also resulted in a corresponding adjustment to the base rent for the lease at the property and increased the annual base rent escalations for the remainder of the lease term.

New Leases

In January 2024, we executed a new lease with a tenant at one of our retail properties in Michigan.

In March 2024, we executed a new long-term lease with a subsidiary of Gold Flora Corporation (“Gold Flora”) at our property located at 63795 19th Avenue in Palm Springs, California (the “19th Ave. Lease”).

In April 2024, we executed a new long-term lease with Lume Cannabis Co. at our property located at 10070 Harvest Park in Dimondale, Michigan.

In May 2024, we executed a new long-term lease with a subsidiary of Gold Flora at our property located at 19533 McLane Street in Palm Springs, California (the “McLane Lease”).

The commencement date under each of the 19th Ave. Lease and McLane Lease is conditioned upon, among other things, the tenant’s receipt of approvals to conduct cannabis operations by the requisite state and local authorities.

Capitalized Costs

During the nine months ended September 30, 2024, we capitalized costs of $45.0 million and funded $45.6 million relating to improvements and construction activities at our properties.

Property Dispositions

In May 2024, we sold our leased property in Los Angeles, California for $9.1 million (excluding closing costs) to a third-party buyer. Concurrently with the sale, pursuant to a separate agreement previously executed between us and the tenant, the tenant paid us a lease termination fee of $3.9 million and paid for the closing and other costs incurred by us in connection with the sale of the property. In connection with this sale, during the nine months ended September 30, 2024, we recognized a disposition-contingent lease termination fee of $3.9 million, which is included in rental revenue (including tenant reimbursements) on our condensed consolidated statements of income, and a loss on sale of real estate of $3.4 million.

In March 2023, we sold the portfolio of four properties in California previously leased to affiliates of Medical Investor Holdings, LLC (“Vertical”) for $16.2 million (excluding transaction costs) and provided a secured loan for $16.1 million to the buyer of the properties. The loan matures on February 29, 2028 with two options to extend the maturity for twelve months, conditional in each instance on the payment of an extension fee and at least $0.5 million of the principal balance. The loan is interest only and payments are payable monthly in advance. The transaction did not qualify for recognition as a completed sale under GAAP since not all of the criteria were met. Accordingly, we have not derecognized the assets transferred on our condensed consolidated balance sheets. All consideration received, as well as any future payments, from the buyer will be recognized as a deposit liability and will be included in other liabilities on our condensed consolidated balance sheet until such time the criteria for recognition as a sale have been met. As of September 30, 2024, we have received interest payments of $2.4 million. In addition, as we have not met all of the held-for-sale criteria, land and building and improvements with a gross carrying value of $3.4 million and $13.9 million, respectively, and accumulated depreciation of $1.9 million as of September 30, 2024, remain on the condensed consolidated balance sheet, and the buildings and improvements continue to be depreciated.

Future Contractual Minimum Rent

Future contractual minimum rent (including base rent and property management fees) to be received on our leases as of September 30, 2024 for future periods is summarized as follows (in thousands):

Year

    

Contractual Minimum Rent

2024 (three months ending December 31)

$

74,500

2025

 

310,800

2026

 

322,415

2027

 

330,720

2028

 

338,062

Thereafter

 

3,978,962

Total

$

5,355,459

Future contractual minimum rent includes payments to be received on two sales-type leases, which will be recognized as a deposit liability and will be included in other liabilities on our condensed consolidated balance sheet until certain criteria are met (see Note 2 “Lease Accounting” for further details).

v3.24.3
Debt
9 Months Ended
Sep. 30, 2024
Debt  
Debt

7. Debt

Exchangeable Senior Notes

During the nine months ended September 30, 2024, we issued 28,408 shares of our common stock and paid $4.3 million in cash upon exchange by holders of $4.3 million principal amount of Exchangeable Senior Notes and paid off the remaining $0.1 million principal amount at maturity in February 2024, in accordance with terms of the indenture for the Exchangeable Senior Notes.

During the nine months ended September 30, 2023, we issued 32,200 shares of our common stock upon exchanges by holders of $2.0 million of outstanding principal amount of our Exchangeable Senior Notes. For the nine months ended September 30, 2023, we recognized a gain on the exchange totaling $22,000, resulting from the difference between the fair value and carrying value of the debt as of the date of the exchange. The issuance of the shares pursuant to the exchanges resulted in a net non-cash increase to our additional paid-in capital account of $2.0 million for the nine months ended September 30, 2023.

The following table details our interest expense related to the Exchangeable Senior Notes which matured in February 2024 (in thousands):

For the Three Months Ended September 30, 

For the Nine Months Ended September 30, 

    

2024

    

2023

    

2024

    

2023

Cash coupon

  

$

  

$

41

  

$

24

  

$

140

Amortization of issuance cost

  

  

9

  

5

  

29

Capitalized interest

(2)

(1)

(2)

Total interest expense

  

$

  

$

48

  

$

28

  

$

167

The following table details the carrying value of our Exchangeable Senior Notes (in thousands):

    

September 30, 2024

    

December 31, 2023

Principal amount

  

$

  

$

4,436

Unamortized issuance cost

  

 

  

(5)

Carrying value

  

$

  

$

4,431

Accrued interest payable for the Exchangeable Senior Notes as of December 31, 2023 was $49,000 and was included in accounts payable and accrued expenses on our condensed consolidated balance sheets.

Notes due 2026

In May 2021, our Operating Partnership issued $300.0 million aggregate principal amount of its 5.50% Senior Notes due 2026 (the “Notes due 2026”). The Notes due 2026 are senior unsecured obligations of our Operating Partnership, are fully and unconditionally guaranteed by us and rank equally in right of payment with all of the Operating Partnership’s future senior unsecured indebtedness. However, the Notes due 2026 are effectively subordinated to any of the Company’s, the Operating Partnership’s and the Operating Partnership’s subsidiaries’ future secured indebtedness to the extent of the value of the assets securing such indebtedness. The Notes due 2026 will pay interest semiannually at a rate of 5.50% per year and will mature on May 25, 2026. The terms of the Notes due 2026 are governed by an indenture dated May 25, 2021, and provide that if the debt rating on the Notes due 2026 is downgraded or withdrawn entirely, interest on the Notes due 2026 will increase to a range of 6.0% to 6.5% based on such debt rating.

In connection with the issuance of the Notes due 2026, we recorded $6.8 million of issuance costs, which are being amortized using the effective interest method and recognized as non-cash interest expense over the term of the Notes due 2026. The effective interest rate including amortization of issuance costs is 6.03%.

The following table details our interest expense related to the Notes due 2026 (in thousands):

For the Three Months Ended September 30, 

For the Nine Months Ended September 30, 

    

2024

2023

    

2024

2023

Cash coupon

$

4,125

$

4,125

$

12,375

$

12,375

Amortization of issuance cost

 

357

335

1,054

992

Capitalized interest

 

(127)

(178)

(516)

(212)

Total interest expense

$

4,355

$

4,282

$

12,913

$

13,155

The following table details the carrying value of our Notes due 2026 (in thousands):

    

September 30, 2024

    

December 31, 2023

Principal amount

  

$

300,000

  

$

300,000

Unamortized issuance cost

  

 

(2,497)

  

(3,551)

Carrying value

  

$

297,503

  

$

296,449

The Operating Partnership may redeem some or all of the Notes due 2026 at its option at any time at the applicable redemption price. If the Notes due 2026 are redeemed prior to February 25, 2026, the redemption price will be equal to 100% of the principal amount of the Notes due 2026 being redeemed, plus a make-whole premium and accrued and unpaid interest thereon to, but excluding, the applicable redemption date. If the Notes due 2026 are redeemed on or after February 25, 2026, the redemption price will be equal to 100% of the principal amount of the Notes due 2026 being redeemed, plus accrued and unpaid interest thereon to, but excluding, the applicable redemption date.

The terms of the indenture for the Notes due 2026 require compliance with various financial covenants, including minimum level of debt service coverage and limits on the amount of total leverage and secured debt maintained by the Operating Partnership. Management believes that it was in compliance with those covenants as of September 30, 2024.

Accrued interest payable for the Notes due 2026 as of September 30, 2024 and December 31, 2023 was $6.2 million and $2.1 million, respectively, and is included in accounts payable and accrued expenses on our condensed consolidated balance sheets.

Revolving Credit Facility

In October 2023, our Operating Partnership entered into a loan and security agreement (the “Loan Agreement”) with a federally regulated commercial bank, as lender and as agent for lenders that become party thereto from time to time, which matures on October 23, 2026. The Loan Agreement provides $50.0 million in aggregate commitments for secured revolving loans (the “Revolving Credit Facility”), the availability of which is based on a borrowing base consisting of real properties owned by subsidiaries (the “Subsidiary Guarantors”) of the Operating Partnership that satisfy eligibility criteria set forth in the Loan Agreement. The obligations of the Operating Partnership under the Loan Agreement are guaranteed by the Company and the Subsidiary Guarantors, and are secured by (i) operating accounts of the Operating Partnership into which lease payments under the real property included in the borrowing base are paid, (ii) the equity interest of the Subsidiary Guarantors, (iii) the real estate included in the borrowing base and the leases and rents thereunder, and (iv) all personal property of the Subsidiary Guarantors. Borrowings under the Revolving Credit Facility bear

interest at a variable rate based on the greater of the prime rate and an applicable margin based on deposits with the participating bank(s) and a stipulated interest rate. The Revolving Credit Facility is subject to an unused line of credit fee, calculated in accordance with the Loan Agreement. The Loan Agreement is subject to certain liquidity and operating covenants and includes customary representations and warranties, affirmative and negative covenants and events of default. The Loan Agreement also allows the Operating Partnership, subject to the satisfaction of certain conditions, to request additional revolving loan commitments up to a specified amount. There were no amounts outstanding under the Revolving Credit Facility as of September 30, 2024.

In connection with the Revolving Credit Facility, we recorded $0.8 million of issuance costs, which are being amortized on a straight-line basis and recognized as non-cash interest expense over the term of the Revolving Credit Facility. For the three and nine months ended September 30, 2024, we recognized $72,000 and $0.2 million, respectively, of non-cash interest expense related to the Revolving Credit Facility.

The following table summarizes the principal payments on our outstanding indebtedness as of September 30, 2024 (in thousands):

Payments Due

by Year

    

Amount

2024 (three months ending December 31)

$

2025

2026

300,000

2027

2028

Thereafter

Total

$

300,000

v3.24.3
Net Income Per Share
9 Months Ended
Sep. 30, 2024
Net Income Per Share  
Net Income Per Share

8. Net Income Per Share

Grants of restricted stock and restricted stock units (“RSUs”) of the Company in share-based payment transactions are considered participating securities prior to vesting and, therefore, are considered in computing basic earnings per share under the two-class method. The two-class method is an earnings allocation method for calculating earnings per share when a company’s capital structure includes either two or more classes of common stock or common stock and participating securities. Earnings per basic share under the two-class method is calculated based on dividends declared on common shares and other participating securities (“distributed earnings”) and the rights of participating securities in any undistributed earnings, which represents net income remaining after deduction of dividends accruing during the period. The undistributed earnings are allocated to all outstanding common shares and participating securities based on the relative percentage of each security to the total number of outstanding participating securities. Earnings per basic share represents the summation of the distributed and undistributed earnings per share class divided by the total number of shares.

Through September 30, 2024, all of the Company’s participating securities received dividends or dividend equivalents at an equal dividend rate per share or unit. As a result, distributions to participating securities for the three and nine months ended September 30, 2024 and 2023 have been included in net income attributable to common stockholders to calculate net income per basic and diluted share.

The 12,647 shares necessary to settle the Exchangeable Senior Notes on the if-exchanged method basis were dilutive for the nine months ended September 30, 2024 and were included in the computation of diluted earnings per share. The 75,682 and 83,007 shares necessary to settle the Exchangeable Senior Notes on the if-exchanged method basis were dilutive for the three and nine months ended September 30, 2023, respectively, and were included in the computation of diluted earnings per share.

For the three and nine months ended September 30, 2024, 25,352 shares issuable upon vesting of the performance share units (“PSUs”) granted to certain employees were included in dilutive securities as the performance thresholds for vesting of the PSUs were met as measured as of September 30, 2024. For the three and nine months ended September 30, 2023, the PSUs granted to certain employees were not included in dilutive securities as the performance thresholds for vesting of the PSUs were not met as measured as of September 30, 2023 (see Note 10 “Common Stock Incentive Plan” for further discussion of PSUs).

Computations of net income per basic and diluted share (in thousands, except share and per share data) were as follows:

For the Three Months Ended

For the Nine Months Ended

September 30, 

September 30, 

    

2024

    

2023

    

2024

    

2023

Net income

$

40,215

$

41,594

$

121,636

$

123,955

Preferred stock dividends

 

(564)

 

(338)

(1,240)

(1,014)

Distribution to participating securities

 

(570)

 

(372)

(1,684)

(1,106)

Net income attributable to common stockholders used to compute net income per share – basic

39,081

40,884

118,712

121,835

Dilutive effect of Exchangeable Senior Notes

50

28

169

Net income attributable to common stockholders used to compute net income per share – diluted

$

39,081

$

40,934

$

118,740

$

122,004

Weighted-average common shares outstanding:

Basic

 

28,254,565

 

27,983,004

28,216,946

27,971,544

Restricted stock and RSUs

299,770

206,919

293,105

193,503

PSUs

25,352

25,352

Dilutive effect of Exchangeable Senior Notes

75,682

12,647

83,007

Diluted

 

28,579,687

 

28,265,605

28,548,050

28,248,054

Net income attributable to common stockholders per share:

Basic

$

1.38

$

1.46

$

4.21

$

4.36

Diluted

$

1.37

$

1.45

$

4.16

$

4.32

v3.24.3
Fair Value of Financial Instruments
9 Months Ended
Sep. 30, 2024
Fair Value of Financial Instruments  
Fair Value of Financial Instruments

9. Fair Value of Financial Instruments

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. Accounting guidance also establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

Level 1—Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.

Level 2—Includes other inputs that are directly or indirectly observable in the marketplace.

Level 3—Unobservable inputs that are supported by little or no market activities, therefore requiring an entity to develop its own assumptions.

The following table presents the carrying value and approximate fair value of financial instruments at September 30, 2024 and December 31, 2023 (in thousands):

At September 30, 2024

At December 31, 2023

                                                                                                          

                                                                                                                         

                                                                                                

                                                                                                                                   

    

Carrying Value

    

Fair Value

    

Carrying Value

    

Fair Value

Investments(1)

$

25,315

$

25,318

$

21,948

$

21,951

Investments as cash equivalents(2)

$

55,104

$

54,996

$

15,187

$

15,029

Exchangeable Senior Notes(3)

$

$

$

4,431

$

7,576

Notes due 2026(3)

$

297,503

$

292,389

$

296,449

$

278,325

Construction Loan(4)

$

22,000

$

27,844

$

22,000

$

27,543

Notes receivable(5)

$

16,796

$

16,796

$

20,028

$

20,028

(1)At September 30, 2024, investments consisting of short-term certificates of deposit with an original maturity at the time of purchase of greater than 90 days and less than one year are classified as held-to-maturity and stated at cost, which approximates fair value, and investments consisting of short-term obligations of the U.S. government with an original maturity at the time of purchase of greater than 90 days and less than one year are classified as held-to-maturity, stated at amortized cost and valued using Level 1 inputs. At December 31, 2023, investments consisting of short-term obligations of the U.S. government with an original maturity at the time of purchase of greater than 90 days and less than one year are classified as held-to-maturity, stated at amortized cost and valued using Level 1 inputs.
(2)Investments as cash equivalents consisting of obligations of the U.S. government with an original maturity at the time of purchase of 90 days or less are classified as held-to-maturity, stated at amortized cost and valued using Level 1 inputs.
(3)The fair value is determined based upon Level 2 inputs as the Exchangeable Senior Notes and Notes due 2026 were not traded in an active market. The Exchangeable Senior Notes matured in February 2024.
(4)The Construction Loan receivable is categorized as Level 3 and was valued using a yield analysis, which is typically performed for non-credit impaired loans. To determine fair value using a yield analysis, a current price is imputed for the loan based upon an assessment of the expected market yield for a similarly structured loan with a similar level of risk. In the yield analysis, the Company considers the current contractual interest rate, the maturity and other terms of the loan relative to risk of the company and the specific loan. At each of September 30, 2024 and December 31, 2023, the expected market yield used to determine fair value was 16.25%. Changes in market yields may change the fair value of the Construction Loan. Generally, an increase in market yields may result in a decrease in the fair value of the Construction Loan. Due to the inherent uncertainty of determining the fair value of a loan that does not have a readily available market value, the fair value of the Construction Loan may fluctuate from period to period. Additionally, the fair value of the Construction Loan may differ significantly from the value that would have been used had a readily available market existed for such loan and may differ materially from the value that the Company may ultimately realize.
(5)Notes receivable relate to certain acquisitions of real estate which did not satisfy the requirements for sale-leaseback accounting (see Note 2 “Acquisition of Real Estate Properties” to our condensed consolidated financial statements for more information). The notes receivable are categorized as Level 3 and were also valued using a yield analysis. At September 30, 2024 and December 31, 2023, the weighted average expected market yields used to determine fair values were 19.7% and 17.2%, respectively.

The carrying amounts of cash equivalents, accounts payable, accrued expenses and other liabilities approximate their fair values.

v3.24.3
Common Stock Incentive Plan
9 Months Ended
Sep. 30, 2024
Common Stock Incentive Plan  
Common Stock Incentive Plan

10. Common Stock Incentive Plan

Our board of directors adopted our 2016 Omnibus Incentive Plan (the “2016 Plan”) to enable us to motivate, attract and retain the services of directors, employees and consultants considered essential to our long-term success. The 2016 Plan offers our directors, employees and consultants an opportunity to own our stock or rights that will reflect our growth, development and financial success. Under the terms of the 2016 Plan, the aggregate number of shares of our common stock subject to options, restricted stock, stock appreciation rights, restricted stock units and other awards, will be no more than 1,000,000 shares. Any equity awards that lapse, expire, terminate, are canceled or are forfeited (including forfeitures in connection with satisfaction of tax withholdings obligations of the recipient) are re-credited to the 2016 Plan’s reserve for future issuance. The 2016 Plan automatically terminates on the date which is ten years following the effective date of the 2016 Plan.

A summary of the restricted stock activity under the 2016 Plan and related information for the nine months ended September 30, 2024 is included in the table below:

    

    

Weighted-

Unvested

Average

Restricted

Grant Date Fair

Stock

Value

Balance at December 31, 2023

 

56,711

$

135.46

Granted

 

43,566

$

91.81

Vested

 

(13,698)

$

126.83

Forfeited(1)

 

(7,442)

$

205.15

Balance at March 31, 2024

 

79,137

$

106.37

Granted

3,186

$

113.05

Vested

(5,055)

$

71.23

Balance at June 30, 2024 and September 30, 2024

77,268

$

108.95

(1)Shares that were forfeited to cover the employees’ tax withholding obligation upon vesting.

The remaining unrecognized compensation cost of $5.2 million for restricted stock awards is expected to be recognized over a weighted-average amortization period of 1.8 years as of September 30, 2024. The fair value of restricted stock that vested during the nine months ended September 30, 2024 was $2.6 million.

The following table summarizes our RSU activity for the nine months ended September 30, 2024. RSUs are issued as part of the Innovative Industrial Properties, Inc. Nonqualified Deferred Compensation Plan (the “Deferred Compensation Plan”), which allows a select group of management and our non-employee directors to defer receiving certain of their cash and equity-based compensation. RSUs are subject to vesting conditions of the Deferred Compensation Plan and have the same economic rights as shares of restricted stock under the 2016 Plan:

    

    

Weighted-Average

Restricted

Grant Date Fair

Stock Units

Value

Balance at December 31, 2023

149,956

$

125.34

Granted

69,714

$

91.81

Balance at March 31, 2024

219,670

$

114.70

Granted

2,832

$

113.05

Balance at June 30, 2024 and September 30, 2024

222,502

$

114.68

The remaining unrecognized compensation cost of $8.0 million for RSU awards is expected to be recognized over an amortization period of 1.8 years as of September 30, 2024.

In January 2021 and 2022, we issued 70,795 and 102,641 “target” PSUs, respectively, to a select group of officers, which vest and are settled in shares of common stock based on the Company’s total stockholder return over a performance period beginning on the applicable grant date and ending on December 31, 2023 and 2024, respectively.

Stock-based compensation for market-based PSU awards is based on the grant date fair value of the equity awards and is recognized over the applicable performance period. For the three months ended September 30, 2024 and 2023, we recognized stock-based compensation expense of $1.7 million and $2.7 million, respectively, relating to PSU awards. For the nine months ended September 30, 2024 and 2023, we recognized stock-based compensation expense of $5.0 million and $8.0 million, respectively, relating to PSU awards. As of September 30, 2024, the remaining unrecognized compensation cost of $1.7 million relating to PSU awards is expected to be recognized over the remaining performance period of 0.3 years.

The PSUs granted in January 2021 were forfeited in their entirety on December 31, 2023 pursuant to the terms of the agreements, as the PSUs failed to meet the performance threshold for vesting.

v3.24.3
Commitments and Contingencies
9 Months Ended
Sep. 30, 2024
Commitments and Contingencies  
Commitments and Contingencies

11. Commitments and Contingencies

Office Lease. The future contractual lease payments for our office lease and the reconciliation to the office lease liability reflected in other liabilities in our condensed consolidated balance sheet as of September 30, 2024 is presented in the table below (in thousands):

Year

    

Amount

2024 (three months ending December 31)

$

128

2025

 

526

2026

 

543

2027

 

45

2028

 

Total future contractual lease payments

 

1,242

Effect of discounting

 

(83)

Office lease liability

$

1,159

Improvement Allowances. As of September 30, 2024, we had $44.2 million of commitments related to improvement allowances, which generally may be requested by the tenants at any time up until a date that is near the expiration of the initial term of the applicable lease.

Construction Commitments. As of September 30, 2024, we had $1.1 million of commitments related to contracts with vendors for improvements at our properties.

Construction Loan. As of September 30, 2024, we had $1.0 million of commitments related to our Construction Loan for the development of a regulated cannabis cultivation and processing facility in California.

Environmental Matters. We follow the policy of monitoring our properties, both targeted acquisition and existing properties, for the presence of hazardous or toxic substances. While there can be no assurance that a material environmental liability does not exist, we are not currently aware of any environmental liabilities that would have a material adverse effect on our financial condition, results of operations and cash flow, or that we believe would require disclosure or the recording of a loss contingency.

Litigation.

Class Action Lawsuit

On April 25, 2022, a federal securities class action lawsuit was filed against the Company and certain of its officers. The case was named Michael V. Mallozzi, individually and on behalf of others similarly situated v. Innovative Industrial Properties, Inc., Paul Smithers, Catherine Hastings and Andy Bui, Case No. 2-22-cv-02359, and was filed in the U.S. District Court for the District of New Jersey. The lawsuit was purportedly brought on behalf of purchasers of our common stock and alleges that we and certain of our officers made false or misleading statements regarding our business in violation of Section 10(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), SEC Rule 10b-5, and Section 20(a) of the Exchange Act. According to the filed complaint, the plaintiff is seeking an undetermined amount of damages, interest, attorneys’ fees and costs and other relief on behalf of the putative classes of all persons who acquired shares of the Company’s common stock between May 7, 2020 and April 13, 2022.

On September 29, 2022, an Amended Class Action Complaint was filed under the same Case Number, adding as defendants Alan D. Gold and Benjamin C. Regin, and asserting causes of action under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. According to the Amended Class Action Complaint, the plaintiff is seeking an undetermined amount of damages, interest, attorneys’ fees and costs and other relief on behalf of the putative classes of all persons who acquired shares of the Company’s common stock between August 7, 2020 and August 4, 2022. On December 1, 2022, defendants moved to dismiss the Amended Class Action Complaint. On September 19, 2023, the court granted defendants’ motion to dismiss the Amended Class Action Complaint without prejudice.

On October 19, 2023, a Second Amended Class Action Complaint was filed under the same Case Number, and asserted causes of action under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. According to the Second Amended Class Action Complaint, the plaintiff is seeking an undetermined amount of damages, interest, attorneys’ fees and costs and other relief on behalf of the putative classes of all persons who acquired shares of the Company’s common stock between August 7, 2020 and August 4, 2022. On December 18, 2023, defendants moved to dismiss the Second Amended Class Action Complaint; on February 1, 2024, plaintiff responded with their opposition to defendants’ motion to dismiss the Second Amended Class Action Complaint; and on March 1, 2024, defendants replied to plaintiff’s response. On September 25, 2024, the court granted defendants’ motion to dismiss the Second Amended Class Action Complaint with prejudice. On September 30, 2024, plaintiff filed a notice of appeal of the court’s dismissal of the Second Amended Class Action Complaint with prejudice.

It is possible that similar lawsuits may yet be filed in the same or other courts that name the same or additional defendants. We intend to defend the lawsuit vigorously. However, at this time, we cannot predict the probable outcome of this action, and, accordingly, no amounts have been accrued in the Company’s condensed consolidated financial statements.

Derivative Action Lawsuits

On July 26, 2022, a derivative action lawsuit was filed against the Company and certain of its officers and directors. The case was named John Rice, derivatively on behalf of Innovative Industrial Properties, Inc. v. Paul Smithers, Catherine Hastings, Andy Bui, Alan Gold, Gary Kreitzer, Mary Curran, Scott Shoemaker, David Stecher, and Innovative Industrial Properties, Inc., Case Number 24-C-22-003312, and was filed in the Circuit Court for Baltimore City, Maryland. The lawsuit asserts putative derivative claims for breach of fiduciary duty, unjust enrichment, abuse of control, gross mismanagement, and waste of corporate assets against the directors and certain officers of the Company. The plaintiffs are seeking declaratory relief, direction to reform and improve corporate governance and internal procedures, and an undetermined amount of damages, restitution, interest, and attorneys’ fees and costs. On September 6, 2022, the defendants in this action filed a Consent Motion to Stay the Proceedings, which was granted on October 11, 2022. On September 28, 2022, a second derivative action lawsuit was filed against the Company and certain of its officers and directors. The case was named Karen Draper, derivatively on behalf of Innovative Industrial Properties, Inc. v. Paul Smithers, Catherine Hastings, Andy Bui, Alan Gold, Gary Kreitzer, Mary Curran, Scott Shoemaker, David Stecher, Defendants, and Innovative Industrial Properties Inc., Nominal Defendant, Case Number 24-C-22-004243, and filed in the Circuit Court for Baltimore City, Maryland. The lawsuit asserts putative derivative claims for breach of fiduciary duty, and seeks actions to reform and improve the Company, and an undetermined amount of damages, restitution, interest, and attorneys’ fees and costs. On October 19, 2022, the parties to both cases filed a Joint Motion to Consolidate Related Shareholder Derivative Actions and to Appoint Lead and Liaison Counsel for plaintiffs, which was granted on December 19, 2022, along with a stay in the lawsuit pending a ruling on the defendants’

motion to dismiss the federal class action lawsuit described above. On April 17, 2023, a third derivative action lawsuit was filed against the Company and certain of its officers and directors. The case was named Ross Weintraub, derivatively on behalf of Innovative Industrial Properties, Inc. v. Alan Gold, Paul Smithers, Catherine Hastings, Ben Regin, Andy Bui, Tracie Hager, Gary Kreitzer, David Stecher, Scott Shoemaker, Mary Curran, and Innovative Industrial Properties, Inc., Case Number 1:23-cv-00737-GLR, and filed in the United States District Court for the District of Maryland. The lawsuit asserts putative derivative claims for breach of fiduciary duty and violations of Section 14(a) of the Exchange Act, and seeks an undetermined amount of damages, equitable relief, and attorneys’ fees and costs. Defendants in this action filed a Consent Motion to Stay the Proceeding, which was granted on April 17, 2023. On June 5, 2023, a fourth derivative action lawsuit was filed against the Company and certain of its officers and directors. The case was named Franco DeBlasio, on behalf of Gerich Melenth Nin (GMN) LP, derivatively on behalf of Innovative Industrial Properties, Inc. v. Paul Smithers, Catherine Hastings, Alan D. Gold, Tracie J. Hager, Benjamin C. Regin, Andy Bui, Gary A. Kreitzer, David Stecher, Scott Shoemaker, Mary Curran, and Innovative Industrial Properties, Inc., Case Number 1:23-cv-01513-GLR, and filed in the United States District Court for the District of Maryland. On July 19, 2023, the United States Court for the District of Maryland consolidated Case Nos. 1:23-cv-00737-GLR and 1:23-cv-01513-GLR with case number 1:23-cv-00737-GLR as the lead case, and kept the stay in place. The consolidated case remains stayed as Case Number 24-C-22-003312.

On May 9, 2024, a fifth derivative action lawsuit was filed against the Company and certain of its officers and directors. The case was named Gary A Gedig, derivatively on behalf of Innovative Industrial Properties, Inc. v. Paul Smithers, Catherine Hastings, Ben Regin, Andy Bui, Tracy Hager, Alan Gold, Gary A. Kreitzer, Mary Curran, Scott Shoemaker, M.D., and David Stecher, and Innovative Industrial Properties, Inc., Civil No. C-24-CV-24-000130, and filed in the Circuit Court for Baltimore City, Maryland. Plaintiff and defendants in this action filed a Joint Stipulation to Stay the Proceedings, which was granted on September 17, 2024.

The Company intends to vigorously defend each of these lawsuits. However, at this time, the Company cannot predict the probable outcome of these actions, and, accordingly, no amounts have been accrued in the Company’s condensed consolidated financial statements.

We may, from time to time, be a party to other legal proceedings, which arise in the ordinary course of our business. Although the results of these proceedings, claims, inquiries, and investigations cannot be predicted with certainty, we do not believe that the final outcome of these matters is reasonably likely to have a material adverse effect on our business, financial condition, or results of operations. Regardless of final outcomes, however, any such proceedings, claims, inquiries, and investigations may nonetheless impose a significant burden on management and employees and may come with significant defense costs or unfavorable preliminary and interim rulings.

v3.24.3
Subsequent Events
9 Months Ended
Sep. 30, 2024
Subsequent Events  
Subsequent Events

12. Subsequent Events

Acquisition

In October 2024, we acquired a 23,000 square foot industrial property in Maryland for $5.6 million and executed a lease with a subsidiary of Maryland Cultivation and Processing, L.L.C. for the entire property.

Amendment to Loan Agreement to Increase Commitments Under Revolving Credit Facility

In November 2024, our Operating Partnership entered into an amendment to the Loan Agreement, pursuant to which the aggregate commitments under the Revolving Credit Facility were increased from $50.0 million to $87.5 million.

v3.24.3
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Pay vs Performance Disclosure        
Net Income (Loss) $ 40,215 $ 41,594 $ 121,636 $ 123,955
v3.24.3
Insider Trading Arrangements
3 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Trading Arrangements, by Individual      
Rule 10b5-1 Arrangement Adopted false false false
Non-Rule 10b5-1 Arrangement Adopted false false false
Rule 10b5-1 Arrangement Terminated false false false
Non-Rule 10b5-1 Arrangement Terminated false false false
v3.24.3
Summary of Significant Accounting Policies and Procedures and Recent Accounting Pronouncements (Policies)
9 Months Ended
Sep. 30, 2024
Summary of Significant Accounting Policies and Procedures and Recent Accounting Pronouncements  
Basis of Presentation

Basis of Presentation. The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements.

This interim financial information should be read in conjunction with the audited consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. Any references to square footage or occupancy percentage, and any amounts derived from these values in these notes to the condensed consolidated financial statements, are outside the scope of our independent registered public accounting firm’s review.

Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. This interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, 2024.

Federal Income Taxes

Federal Income Taxes. We believe that we have operated our business so as to qualify to be taxed as a REIT for U.S. federal income tax purposes. Under the REIT operating structure, we are permitted to deduct dividends paid to our stockholders in determining our taxable income. Assuming our dividends equal or exceed our taxable net income, we generally will not be required to pay federal corporate income taxes on such income. The income taxes recorded on our condensed consolidated statements of income represent amounts paid for city and state income and franchise taxes and are included in general and administrative expenses in the accompanying condensed consolidated statements of income.

Use of Estimates

Use of Estimates. The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make a number of estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the condensed consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Actual results may differ materially from these estimates and assumptions. The most significant estimates and assumptions made include the determination of lease accounting and fair value of acquisition of real estate properties.

Reportable Segment

Reportable Segment. We are engaged in the business of providing real estate for the regulated cannabis industry. Our properties are similar in that they are leased to the state-licensed operators on a long-term triple-net basis, consist of improvements that are reusable and have similar economic characteristics. Our chief operating decision maker reviews financial information for our entire consolidated operations when making decisions related to assessing our operating performance. We have aggregated the properties into one reportable segment as the properties share similar long-term economic characteristics and have other similarities, including the fact that they are operated using consistent business strategies. The financial information disclosed herein represents all of the financial information related to our one reportable segment.

Acquisition of Real Estate Properties

Acquisition of Real Estate Properties. Our investment in real estate is recorded at historical cost, less accumulated depreciation. Upon acquisition of a property, the tangible and intangible assets acquired and liabilities assumed are initially measured based upon their relative fair values. We estimate the fair value of land by reviewing comparable sales within the same submarket and/or region. We estimate the fair value of buildings and improvements as if the property was vacant, taking into consideration current replacement costs and other relevant market rate information and may engage third-party valuation specialists. Acquisition costs are capitalized as incurred. All of our acquisitions to date were recorded as asset acquisitions.

The fair value of acquired in-place leases is derived based on our assessment of estimated lost revenue and costs incurred for the period required to lease the “assumed vacant” property to the occupancy level when purchased. The amounts recorded for acquired in-place leases are reflected as in-place lease intangible assets, net on our condensed consolidated balance sheets and are amortized on a straight-line basis as a component of depreciation and amortization expense over the remaining term of the applicable leases.

The fair value of the above-market component of an acquired in-place operating lease is based upon the present value (calculated using a market discount rate) of the difference between (i) the contractual rents to be paid pursuant to the lease over its remaining non-cancellable lease term and (ii) our estimate of the rents that would be paid using fair market rental rates and rent escalations at the date of acquisition measured over the remaining non-cancellable term of the lease. The amount recorded for one above-market operating lease is included in other assets, net on our condensed consolidated balance sheets and is amortized on a straight-line basis as a reduction of rental revenues over the remaining term of the applicable lease.

Certain acquisitions of real estate did not satisfy the requirements for sale-leaseback accounting and therefore as of September 30, 2024 and December 31, 2023, acquisitions of $16.8 million and $20.0 million, respectively have been recognized as notes receivable and are included in other assets, net on our condensed consolidated balance sheets. During the three months ended September 30, 2024, a $3.2 million acquisition of real estate which previously did not satisfy the requirements for sale-leaseback accounting was reclassified to real estate held for investment as the requirements for sale-leaseback accounting were satisfied.

Sale of Real Estate

Sale of Real Estate. When a real estate asset is sold, we evaluate the provisions of Accounting Standards Codification (“ASC”) 610-20, Gains and Losses from the Derecognition of Nonfinancial Assets (“ASC 610-20”) to determine whether the asset is within the scope of ASC 610-20, including an evaluation of whether the asset being sold is a nonfinancial asset and whether the buyer has gained control of an asset within the scope of ASC 610-20. In assessing whether the buyer has gained control of the asset, we must determine whether the contract criteria in ASC 606, Revenue from Contracts with Customers (Topic 606) have been met, including 1) the parties to the contract have approved the contract and the contract has commercial substance, 2) we can identify each party’s rights regarding the asset to be transferred, 3) we can identify the payment terms for the asset to be transferred, and 4) it is probable that we will collect substantially all of the consideration to which we will be entitled in exchange for the asset to be transferred. If all of the contract criteria have been met, the carrying amount of the applicable asset is derecognized with a corresponding gain or loss from the sale recognized in our consolidated statements of income. If the contract criteria are not all met, the asset transferred is not derecognized and we continue to report the asset in our condensed consolidated balance sheet. See Note 6 “Investments in Real Estate - Property Disposition” for further information.

Cost Capitalization and Depreciation

Cost Capitalization and Depreciation. We capitalize costs (including interest) associated with development and redevelopment activities and improvements when we are considered to be the accounting owner of the resulting assets. The development and redevelopment activities may be funded by us pursuant to the lease. We are generally considered the accounting owner for such improvements that are attached to or built into the premises, which are required under the lease to be surrendered to us upon the expiration or earlier termination of the lease. Typically, such improvements include, but are not limited to, ground up development, and enhanced HVAC, plumbing, electrical and other building systems.

Amounts capitalized are depreciated on a straight-line basis over the estimated useful lives determined by management. We depreciate buildings and improvements based on our evaluation of the estimated useful life of each specific asset, not to exceed 40 years. For the three months ended September 30, 2024 and 2023, we recognized depreciation expense of $17.7 million and $16.5 million, respectively, and for the nine months ended September 30, 2024 and 2023, we recognized depreciation expense of $51.9 million and $49.5 million, respectively. Depreciation expense relating to our real estate held for investment is included in depreciation

and amortization expense in our condensed consolidated statements of income. We depreciate office equipment and furniture and fixtures on a straight-line basis over the estimated useful lives ranging from three to seven years. We depreciate the leasehold improvements at our corporate office on a straight-line basis over the shorter of the estimated useful lives or the remaining lease term. Depreciation expense relating to our corporate assets is included in general and administrative expense in our condensed consolidated statements of income.

Determining whether expenditures meet the criteria for capitalization and the assignment of depreciable lives requires management to exercise significant judgment. Project costs that are clearly associated with the acquisition and development or redevelopment of a real estate project, for which we are the accounting owner, are capitalized as a cost of that project. Expenditures that meet one or more of the following criteria generally qualify for capitalization:

the expenditure provides benefit in future periods; and
the expenditure extends the useful life of the asset beyond our original estimates.

We define redevelopment properties as existing properties for which we expect to spend significant development and construction costs that are not reimbursements to tenants for improvements at the properties. When existing properties are determined to be redevelopment properties, the net carrying value of the buildings and improvements are transferred to construction in progress while the redevelopment activities are in process. Costs capitalized to construction in progress related to redevelopment properties are transferred to buildings and improvements at historical cost of the properties as the redevelopment project or phases of projects are placed in service.

Provision for Impairment

Provision for Impairment. On a quarterly basis, we review current activities and changes in the business conditions of all of our properties prior to and subsequent to the end of each quarter to determine the existence of any triggering events or impairment indicators requiring an impairment analysis. If triggering events or impairment indicators are identified, we review an estimate of the future undiscounted cash flows for the properties.

Long-lived assets are individually evaluated for impairment when conditions exist that may indicate that the carrying amount of a long-lived asset may not be recoverable. The carrying amount of a long-lived asset to be held and used is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. Impairment indicators or triggering events for long-lived assets to be held and used are assessed by project and include significant fluctuations in estimated net operating income, occupancy changes, significant near-term lease expirations, current and historical operating and/or cash flow losses, construction costs, estimated completion dates, rental rates, and other market factors. We assess the expected undiscounted cash flows based upon numerous factors, including, but not limited to, construction costs, available market information, current and historical operating results, known trends, current market/economic conditions that may affect the property, and our assumptions about the use of the asset, including, if necessary, a probability-weighted approach if multiple outcomes are under consideration. Upon determination that an impairment has occurred, a write-down is recognized to reduce the carrying amount to its estimated fair value. We may adjust depreciation of properties that are expected to be disposed of or redeveloped prior to the end of their useful lives. No impairment losses were recognized during the three and nine months ended September 30, 2024 and 2023.

Revenue Recognition

Revenue Recognition. Our leases are triple-net leases, an arrangement under which the tenant maintains the property while paying us rent. We recognize revenue for each of the leases at our properties that are classified as operating leases on a cash basis due to the uncertain regulatory environment in the United States pertaining to the regulated cannabis industry, the limited operating history of certain tenants and the resulting uncertainty of collectability of lease payments from each tenant over the duration of the lease term. Additionally, for operating leases, contractually obligated reimbursements from tenants for recoverable real estate taxes, insurance and operating expenses are included in rental revenues in the period when such costs are incurred and reimbursed by the tenants. Contractually obligated real estate taxes that are paid directly by the tenant to the tax authorities are not reflected in our condensed consolidated financial statements.

For the three and nine months ended September 30, 2024, rental revenue recognized included the application of $1.4 million and $2.0 million of security deposits for rent, respectively. For the three and nine months ended September 30, 2023, rental revenue recognized included the application of $2.2 million and $8.0 million of security deposits for rent, respectively.

Construction Loan

Construction Loan. We executed a construction loan agreement with a developer, pursuant to which we agreed to lend up to $23.0 million for the development of a regulated cannabis cultivation and processing facility in California (the “Construction Loan”). We have an option to purchase the property, and may execute a negotiated lease with an affiliate of the developer or with another third party, if we determine to exercise our purchase option. The Construction Loan matures on December 31, 2024. As of both September

30, 2024 and December 31, 2023, we had funded $22.0 million of the $23.0 million total commitment. Interest income on the Construction Loan is recognized on a cash basis.

Cash and Cash Equivalents

Cash and Cash Equivalents. We consider all highly-liquid investments with original maturities of 90 days or less to be cash equivalents, which is comprised of short-term money market funds, obligations of the U.S. government and certificates of deposit with an original maturity at the time of purchase of less than or equal to 90 days.

Restricted Cash

Restricted Cash. Restricted cash relates to cash held in escrow accounts for future draws for improvements for tenants in accordance with certain lease agreements.

Investments

Investments. Investments consist of short-term obligations of the U.S. government and certificates of deposit with an original maturity at the time of purchase of greater than 90 days. Investments in obligations of the U.S. government are classified as held-to-maturity and stated at amortized cost. Investments in certificates of deposit are classified as held-to-maturity and stated at cost.

Deferred Financing Costs

Deferred Financing Costs. The deferred financing costs relating to our Notes due 2026 are included as a reduction in the net book value of the related liability on our condensed consolidated balance sheet. These costs are amortized as non-cash interest expense using the effective interest method over the life of the related obligations. Deferred financing costs relating to our Revolving Credit Facility are included in other assets, net in our condensed consolidated balance sheets. These costs are being amortized on a straight-line basis and recognized as non-cash interest expense over the remaining term of the Revolving Credit Facility.

Stock-Based Compensation

Stock-Based Compensation. Stock-based compensation for equity awards is based on the grant date fair value of the equity awards and is recognized over the requisite service or performance period. If awards are forfeited prior to vesting, we reverse any previously recognized expense related to such awards in the period during which the forfeiture occurs and reclassify any non-forfeitable dividends and dividend equivalents previously paid on these awards from retained earnings to compensation expense. Forfeitures are recognized as incurred. Certain equity awards are subject to vesting based upon the satisfaction of various market conditions. Forfeiture of share awards with market-based restrictions does not result in a reversal of previously recognized share-based compensation expense.

Lease Accounting

Lease Accounting. We account for our leases under ASC 842, Leases, and have elected the practical expedient not to separate certain non-lease components from the lease component if the timing and pattern of transfer are the same for the non-lease component and associated lease component, and the lease component would be classified as an operating lease if accounted for separately. We also elected the short-term lease exception for lessees for leases that are less than 12 months. As lessee, we recognized a liability to account for our future obligations and a corresponding right-of-use asset related to our corporate office lease, which ends in January 2027 and contains annual escalations. We measured the lease liability based on the present value of the future lease payments (excluding the extension option that we are not reasonably certain to exercise), discounted using the estimated incremental borrowing rates of 7.25% and 5.5%, which were the interest rates that we estimated we would have to pay to borrow on a collateralized basis over a similar term for an amount equal to the lease payments at initial commencement in December 2019 and upon an amendment in November 2021, respectively. Subsequently, the lease liability is accreted by applying a discount rate established at the lease commencement date to the lease liability balance as of the beginning of the period and is reduced by the payments made during the period.

The right-of-use asset is measured based on the corresponding lease liability. We did not incur any initial direct leasing costs or exchange any other consideration with the landlord prior to the commencement of the lease. Subsequently, the right-of-use asset is amortized on a straight-line basis during the lease term. In each of the three and nine months ended September 30, 2024 and 2023, we recognized office lease expense of $0.1 million and $0.4 million, respectively, which is included in general and administrative expenses in our condensed consolidated statements of income. In each of the nine months ended September 30, 2024 and 2023, amounts paid and classified as operating activities in our condensed consolidated statements of cash flows for the office lease were $0.4 million.

As lessor, for each of our real estate transactions involving the leaseback of the related property to the seller or affiliates of the seller, we determine whether these transactions qualify as sale and leaseback transactions under the accounting guidance. For these transactions, we consider various inputs and assumptions including, but not necessarily limited to, lease terms, renewal options, discount rates, and other rights and provisions in the purchase and sale agreement, lease and other documentation to determine whether control has been transferred to the Company or remains with the lessee. A transaction involving a sale leaseback will be treated as a purchase of a real estate property if it is considered to transfer control of the underlying asset from the lessee. A lease will be classified as direct-financing if risks and rewards are conveyed without the transfer of control and will be classified as a sales-type lease if control of the underlying asset is transferred to the lessee. Otherwise, the lease is treated as an operating lease. These criteria also include estimates and assumptions regarding the fair value of the leased facilities, minimum lease payments, the economic useful

life of the facilities, the existence of a purchase option, and certain other terms in the lease agreements. The lease accounting guidance requires accounting for a transaction as a financing in a sale leaseback when the seller-lessee is provided an option to purchase the property from the landlord at the tenant’s option. Substantially all of our leases are classified as operating leases.

Lease amendments are evaluated to determine if the modification grants the lessee an additional right-of-use not included in the original lease and if the lease payments increase commensurate with the standalone price of the additional right-of-use, adjusted for the circumstances of the particular contract. If both conditions are present, the lease amendment is accounted for as a new lease that is separate from the original lease. In January 2024, the lease modifications for two of our leases to extend the initial term of each lease changed the lease classification from operating lease to sales-type lease that did not satisfy all the criteria for recognition as a completed sale. Accordingly, we have not derecognized the underlying assets and all lease payments received, as well as any future lease payments, will be recognized as a deposit liability and will be included in other liabilities on our condensed consolidated balance sheet until certain criteria are met. As of September 30, 2024, we have received lease payments of $4.4 million that have been included in other liabilities on our condensed consolidated balance sheet. The underlying assets’ land and building and improvements had a gross carrying value of $4.1 million and $28.9 million, respectively, and accumulated depreciation of $3.3 million as of September 30, 2024.

Our leases generally contain options to extend the lease terms at the prevailing market rate or at the expiring rental rate at the time of expiration. Certain of our leases provide the lessee with a right of first refusal or right of first offer in the event we market the leased property for sale.

Recent Accounting Pronouncements

Recent Accounting Pronouncements. In November 2023, the Financial Accounting Standards Board issued Accounting Standards Update 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”). The amendments in ASU 2023-07 improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses, measures of segment profit and loss, and disclosures of how the chief operating decision maker uses the reported measure(s) of a segment’s profit or loss in assessing segment performance and deciding how to allocate resources. The amendments are effective for all public entities that are required to report segment information for fiscal years beginning after December 15, 2023 and interim periods beginning after December 15, 2024. ASU 2023-07 also requires a public entity that has a single reportable segment to provide all the disclosures required by the amendments in ASU 2023-07 and all existing segment disclosures in Topic 280. Early adoption is permitted. The amendments should be applied retrospectively to all prior periods presented. The Company is currently evaluating the potential impact that this standard will have on its condensed consolidated financial statements and related disclosures.

Concentration of Credit Risk

Concentration of Credit Risk. As of September 30, 2024, we owned 108 properties located in 19 states and leased to 30 tenants (excluding three non-cannabis tenants at two of our properties). The ability of any of our tenants to honor the terms of their leases is dependent upon the economic, regulatory, competition, natural and social factors affecting the community in which that tenant operates.

The following table sets forth the five tenants in our portfolio that represented the largest percentage of our total rental revenues for the three and nine months ended September 30, 2024 and 2023, including tenant reimbursements:

For the Three Months Ended

 

September 30, 2024

Percentage of

    

Number of 

    

 Rental 

 

    

Leases

    

Revenue

PharmaCann Inc. ("PharmaCann")

 

11

17

%

Ascend Wellness Holdings, Inc. ("Ascend")

 

4

11

%

Green Thumb Industries, Inc. ("Green Thumb")

 

3

8

%

Curaleaf Holdings, Inc. ("Curaleaf")

 

8

7

%

Trulieve Cannabis Corp. ("Trulieve")

6

7

%

For the Nine Months Ended

 

September 30, 2024

Percentage of

    

Number of 

    

 Rental 

 

    

Leases

    

Revenue

PharmaCann

 

11

17

%

Ascend

4

11

%

Green Thumb

 

3

8

%

Holistic Industries Inc.

 

5

8

%

Curaleaf

8

7

%

For the Three Months Ended

September 30, 2023

    

    

Percentage of 

    

 

Number of 

 

Rental 

 

    

Leases

    

Revenue

    

PharmaCann

11

15

%

Ascend

4

10

%

Green Thumb

3

8

%

Curaleaf

8

7

%

Trulieve

6

7

%

For the Nine Months Ended

 

September 30, 2023

Percentage of

    

Number of 

    

 Rental 

 

    

Leases

    

Revenue

PharmaCann

 

11

15

%

Ascend

4

10

%

Green Thumb

 

3

8

%

Curaleaf

8

7

%

SH Parent, Inc. ("Parallel")(1)

 

4

7

%

(1)We regained possession of two properties previously leased to Parallel in Texas and Pennsylvania in 2023.

In each of the tables above, these leases include leases with affiliates of each entity, for which the entity has provided a corporate guaranty.

As of September 30, 2024 and December 31, 2023, our largest property was located in New York and accounted for 5.5% and 5.4%, respectively, of our net real estate held for investment. No other properties accounted for more than 5% of our net real estate held for investment as of September 30, 2024 and December 31, 2023.

We have deposited cash with financial institutions that are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. As of September 30, 2024, we had cash accounts in excess of FDIC insured limits. We have not experienced any losses in such accounts.

v3.24.3
Summary of Significant Accounting Policies and Procedures and Recent Accounting Pronouncements (Tables)
9 Months Ended
Sep. 30, 2024
Summary of Significant Accounting Policies and Procedures and Recent Accounting Pronouncements  
Schedule of tenants in the company's portfolio that represented the largest percentage of total rental revenue for each period presented, including tenant reimbursements

The following table sets forth the five tenants in our portfolio that represented the largest percentage of our total rental revenues for the three and nine months ended September 30, 2024 and 2023, including tenant reimbursements:

For the Three Months Ended

 

September 30, 2024

Percentage of

    

Number of 

    

 Rental 

 

    

Leases

    

Revenue

PharmaCann Inc. ("PharmaCann")

 

11

17

%

Ascend Wellness Holdings, Inc. ("Ascend")

 

4

11

%

Green Thumb Industries, Inc. ("Green Thumb")

 

3

8

%

Curaleaf Holdings, Inc. ("Curaleaf")

 

8

7

%

Trulieve Cannabis Corp. ("Trulieve")

6

7

%

For the Nine Months Ended

 

September 30, 2024

Percentage of

    

Number of 

    

 Rental 

 

    

Leases

    

Revenue

PharmaCann

 

11

17

%

Ascend

4

11

%

Green Thumb

 

3

8

%

Holistic Industries Inc.

 

5

8

%

Curaleaf

8

7

%

For the Three Months Ended

September 30, 2023

    

    

Percentage of 

    

 

Number of 

 

Rental 

 

    

Leases

    

Revenue

    

PharmaCann

11

15

%

Ascend

4

10

%

Green Thumb

3

8

%

Curaleaf

8

7

%

Trulieve

6

7

%

For the Nine Months Ended

 

September 30, 2023

Percentage of

    

Number of 

    

 Rental 

 

    

Leases

    

Revenue

PharmaCann

 

11

15

%

Ascend

4

10

%

Green Thumb

 

3

8

%

Curaleaf

8

7

%

SH Parent, Inc. ("Parallel")(1)

 

4

7

%

(1)We regained possession of two properties previously leased to Parallel in Texas and Pennsylvania in 2023.

In each of the tables above, these leases include leases with affiliates of each entity, for which the entity has provided a corporate guaranty.

v3.24.3
Dividends (Tables)
9 Months Ended
Sep. 30, 2024
Dividends  
Schedule of dividends declared

The following table describes the dividends declared by the Company during the nine months ended September 30, 2024:

    

    

Amount

    

    

Dividend

    

Dividend

Declaration Date

Security Class

Per Share

Period Covered

Paid Date

Amount

 

(In thousands)

March 15, 2024

Common stock

$

1.82

January 1, 2024 to March 31, 2024

April 15, 2024

$

51,957

March 15, 2024

Series A preferred stock

$

0.5625

January 15, 2024 to April 14, 2024

April 15, 2024

$

338

June 14, 2024

Common stock

$

1.90

April 1, 2024 to June 30, 2024

July 15, 2024

$

54,253

June 14, 2024

Series A preferred stock

$

0.5625

April 15, 2024 to July 14, 2024

July 15, 2024

$

338

September 13, 2024

Common stock

$

1.90

July 1, 2024 to September 30, 2024

October 15, 2024

$

54,253

September 13, 2024

Series A preferred stock

$

0.5625

July 15, 2024 to October 14, 2024

October 15, 2024

$

564

v3.24.3
Investments in Real Estate (Tables)
9 Months Ended
Sep. 30, 2024
Schedule of real estate properties

The Company made the following acquisition during the nine months ended September 30, 2024 (dollars in thousands):

Rentable 

 Square

 Purchase

Transaction

Property

    

Market

    

Closing Date

    

Feet(1)

    

 Price

    

 Costs

    

Total

Ocala

 

Florida

June 7, 2024

 

145,000

$

13,000

$

26

$

13,026

(2)

Total

 

145,000

$

13,000

$

26

$

13,026

(3)

(1)Includes expected rentable square feet at completion of construction at the property.
(2)The tenant is expected to complete improvements at the property, for which we agreed to provide funding of up to $30.0 million.
(3)$2.1 million was allocated to land and $10.9 million was allocated to building and improvements.
Schedule of future contractual minimum rent

Future contractual minimum rent (including base rent and property management fees) to be received on our leases as of September 30, 2024 for future periods is summarized as follows (in thousands):

Year

    

Contractual Minimum Rent

2024 (three months ending December 31)

$

74,500

2025

 

310,800

2026

 

322,415

2027

 

330,720

2028

 

338,062

Thereafter

 

3,978,962

Total

$

5,355,459

Acquired In-Place Lease Intangible Assets  
Schedule of intangible assets and related accumulated amortization

In-place lease intangible assets and related accumulated amortization as of September 30, 2024 and December 31, 2023 is as follows (in thousands):

    

September 30, 2024

    

December 31, 2023

In-place lease intangible assets

$

9,979

$

9,979

Accumulated amortization

 

 

(2,379)

 

(1,734)

In-place lease intangible assets, net

$

7,600

$

8,245

Schedule of estimated annual amortization

Year

    

Amount

2024 (three months ending December 31)

$

215

2025

 

860

2026

 

860

2027

 

860

2028

860

Thereafter

 

3,945

Total

$

7,600

Above-Market Lease  
Schedule of intangible assets and related accumulated amortization

The above-market lease and related accumulated amortization included in other assets, net on our condensed consolidated balance sheets as of September 30, 2024 and December 31, 2023 is as follows (in thousands):

    

September 30, 2024

    

December 31, 2023

Above-market lease

$

1,054

$

1,054

Accumulated amortization

 

 

(256)

 

(187)

Above-market lease, net

$

798

$

867

v3.24.3
Debt (Tables)
9 Months Ended
Sep. 30, 2024
Summary of principal payments on outstanding indebtedness

The following table summarizes the principal payments on our outstanding indebtedness as of September 30, 2024 (in thousands):

Payments Due

by Year

    

Amount

2024 (three months ending December 31)

$

2025

2026

300,000

2027

2028

Thereafter

Total

$

300,000

Exchangeable Senior Notes  
Schedule of interest expense

The following table details our interest expense related to the Exchangeable Senior Notes which matured in February 2024 (in thousands):

For the Three Months Ended September 30, 

For the Nine Months Ended September 30, 

    

2024

    

2023

    

2024

    

2023

Cash coupon

  

$

  

$

41

  

$

24

  

$

140

Amortization of issuance cost

  

  

9

  

5

  

29

Capitalized interest

(2)

(1)

(2)

Total interest expense

  

$

  

$

48

  

$

28

  

$

167

Schedule of carrying value

The following table details the carrying value of our Exchangeable Senior Notes (in thousands):

    

September 30, 2024

    

December 31, 2023

Principal amount

  

$

  

$

4,436

Unamortized issuance cost

  

 

  

(5)

Carrying value

  

$

  

$

4,431

Notes due 2026  
Schedule of interest expense

The following table details our interest expense related to the Notes due 2026 (in thousands):

For the Three Months Ended September 30, 

For the Nine Months Ended September 30, 

    

2024

2023

    

2024

2023

Cash coupon

$

4,125

$

4,125

$

12,375

$

12,375

Amortization of issuance cost

 

357

335

1,054

992

Capitalized interest

 

(127)

(178)

(516)

(212)

Total interest expense

$

4,355

$

4,282

$

12,913

$

13,155

Schedule of carrying value

The following table details the carrying value of our Notes due 2026 (in thousands):

    

September 30, 2024

    

December 31, 2023

Principal amount

  

$

300,000

  

$

300,000

Unamortized issuance cost

  

 

(2,497)

  

(3,551)

Carrying value

  

$

297,503

  

$

296,449

v3.24.3
Net Income Per Share (Tables)
9 Months Ended
Sep. 30, 2024
Net Income Per Share  
Schedule of computations of net income per basic and diluted share

Computations of net income per basic and diluted share (in thousands, except share and per share data) were as follows:

For the Three Months Ended

For the Nine Months Ended

September 30, 

September 30, 

    

2024

    

2023

    

2024

    

2023

Net income

$

40,215

$

41,594

$

121,636

$

123,955

Preferred stock dividends

 

(564)

 

(338)

(1,240)

(1,014)

Distribution to participating securities

 

(570)

 

(372)

(1,684)

(1,106)

Net income attributable to common stockholders used to compute net income per share – basic

39,081

40,884

118,712

121,835

Dilutive effect of Exchangeable Senior Notes

50

28

169

Net income attributable to common stockholders used to compute net income per share – diluted

$

39,081

$

40,934

$

118,740

$

122,004

Weighted-average common shares outstanding:

Basic

 

28,254,565

 

27,983,004

28,216,946

27,971,544

Restricted stock and RSUs

299,770

206,919

293,105

193,503

PSUs

25,352

25,352

Dilutive effect of Exchangeable Senior Notes

75,682

12,647

83,007

Diluted

 

28,579,687

 

28,265,605

28,548,050

28,248,054

Net income attributable to common stockholders per share:

Basic

$

1.38

$

1.46

$

4.21

$

4.36

Diluted

$

1.37

$

1.45

$

4.16

$

4.32

v3.24.3
Fair Value of Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2024
Fair Value of Financial Instruments  
Schedule of carrying value and approximate fair value of financial instruments

The following table presents the carrying value and approximate fair value of financial instruments at September 30, 2024 and December 31, 2023 (in thousands):

At September 30, 2024

At December 31, 2023

                                                                                                          

                                                                                                                         

                                                                                                

                                                                                                                                   

    

Carrying Value

    

Fair Value

    

Carrying Value

    

Fair Value

Investments(1)

$

25,315

$

25,318

$

21,948

$

21,951

Investments as cash equivalents(2)

$

55,104

$

54,996

$

15,187

$

15,029

Exchangeable Senior Notes(3)

$

$

$

4,431

$

7,576

Notes due 2026(3)

$

297,503

$

292,389

$

296,449

$

278,325

Construction Loan(4)

$

22,000

$

27,844

$

22,000

$

27,543

Notes receivable(5)

$

16,796

$

16,796

$

20,028

$

20,028

(1)At September 30, 2024, investments consisting of short-term certificates of deposit with an original maturity at the time of purchase of greater than 90 days and less than one year are classified as held-to-maturity and stated at cost, which approximates fair value, and investments consisting of short-term obligations of the U.S. government with an original maturity at the time of purchase of greater than 90 days and less than one year are classified as held-to-maturity, stated at amortized cost and valued using Level 1 inputs. At December 31, 2023, investments consisting of short-term obligations of the U.S. government with an original maturity at the time of purchase of greater than 90 days and less than one year are classified as held-to-maturity, stated at amortized cost and valued using Level 1 inputs.
(2)Investments as cash equivalents consisting of obligations of the U.S. government with an original maturity at the time of purchase of 90 days or less are classified as held-to-maturity, stated at amortized cost and valued using Level 1 inputs.
(3)The fair value is determined based upon Level 2 inputs as the Exchangeable Senior Notes and Notes due 2026 were not traded in an active market. The Exchangeable Senior Notes matured in February 2024.
(4)The Construction Loan receivable is categorized as Level 3 and was valued using a yield analysis, which is typically performed for non-credit impaired loans. To determine fair value using a yield analysis, a current price is imputed for the loan based upon an assessment of the expected market yield for a similarly structured loan with a similar level of risk. In the yield analysis, the Company considers the current contractual interest rate, the maturity and other terms of the loan relative to risk of the company and the specific loan. At each of September 30, 2024 and December 31, 2023, the expected market yield used to determine fair value was 16.25%. Changes in market yields may change the fair value of the Construction Loan. Generally, an increase in market yields may result in a decrease in the fair value of the Construction Loan. Due to the inherent uncertainty of determining the fair value of a loan that does not have a readily available market value, the fair value of the Construction Loan may fluctuate from period to period. Additionally, the fair value of the Construction Loan may differ significantly from the value that would have been used had a readily available market existed for such loan and may differ materially from the value that the Company may ultimately realize.
(5)Notes receivable relate to certain acquisitions of real estate which did not satisfy the requirements for sale-leaseback accounting (see Note 2 “Acquisition of Real Estate Properties” to our condensed consolidated financial statements for more information). The notes receivable are categorized as Level 3 and were also valued using a yield analysis. At September 30, 2024 and December 31, 2023, the weighted average expected market yields used to determine fair values were 19.7% and 17.2%, respectively.
v3.24.3
Common Stock Incentive Plan (Tables)
9 Months Ended
Sep. 30, 2024
Restricted Shares  
Common Stock Incentive Plan  
Summary of the activity

A summary of the restricted stock activity under the 2016 Plan and related information for the nine months ended September 30, 2024 is included in the table below:

    

    

Weighted-

Unvested

Average

Restricted

Grant Date Fair

Stock

Value

Balance at December 31, 2023

 

56,711

$

135.46

Granted

 

43,566

$

91.81

Vested

 

(13,698)

$

126.83

Forfeited(1)

 

(7,442)

$

205.15

Balance at March 31, 2024

 

79,137

$

106.37

Granted

3,186

$

113.05

Vested

(5,055)

$

71.23

Balance at June 30, 2024 and September 30, 2024

77,268

$

108.95

(1)Shares that were forfeited to cover the employees’ tax withholding obligation upon vesting.
RSUs  
Common Stock Incentive Plan  
Summary of the activity

The following table summarizes our RSU activity for the nine months ended September 30, 2024. RSUs are issued as part of the Innovative Industrial Properties, Inc. Nonqualified Deferred Compensation Plan (the “Deferred Compensation Plan”), which allows a select group of management and our non-employee directors to defer receiving certain of their cash and equity-based compensation. RSUs are subject to vesting conditions of the Deferred Compensation Plan and have the same economic rights as shares of restricted stock under the 2016 Plan:

    

    

Weighted-Average

Restricted

Grant Date Fair

Stock Units

Value

Balance at December 31, 2023

149,956

$

125.34

Granted

69,714

$

91.81

Balance at March 31, 2024

219,670

$

114.70

Granted

2,832

$

113.05

Balance at June 30, 2024 and September 30, 2024

222,502

$

114.68

v3.24.3
Commitments and Contingencies (Tables)
9 Months Ended
Sep. 30, 2024
Commitments and Contingencies  
Schedule of future contractual lease payments

Office Lease. The future contractual lease payments for our office lease and the reconciliation to the office lease liability reflected in other liabilities in our condensed consolidated balance sheet as of September 30, 2024 is presented in the table below (in thousands):

Year

    

Amount

2024 (three months ending December 31)

$

128

2025

 

526

2026

 

543

2027

 

45

2028

 

Total future contractual lease payments

 

1,242

Effect of discounting

 

(83)

Office lease liability

$

1,159

v3.24.3
Organization (Details)
Sep. 30, 2024
IIP Operating Partnership, LP  
Percentage of limited partnership interests 100.00%
v3.24.3
Summary of Significant Accounting Policies and Procedures and Recent Accounting Pronouncements - Additional Information (Details)
1 Months Ended 3 Months Ended 9 Months Ended
Jan. 31, 2024
lease
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
segment
Sep. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
Nov. 30, 2021
Dec. 31, 2019
Number of reportable segment | segment       1        
Reclassification from other assets to real estate held for investment   $ 3,200,000   $ 3,152,000        
Depreciation expense   17,700,000 $ 16,500,000 51,900,000 $ 49,500,000      
Impairment losses   0 0 0 0      
Rental revenue   1,400,000 2,200,000 2,000,000.0 8,000,000.0      
Construction loan funded   22,000,000   22,000,000   $ 22,000,000    
Construction loan, total commitment amount   23,000,000.0   $ 23,000,000.0   23,000,000.0    
Lease, Practical Expedients, Package       true        
Incremental borrowing rate             5.50% 7.25%
Amounts paid and classified as operating activities for the office lease       $ 400,000 400,000      
Number of lease modifications | lease 2              
Underlying assets accumulated depreciation   3,300,000   3,300,000        
Other assets, net                
Acquisitions of real estate did not satisfy the requirements for sale-leaseback accounting   16,800,000   16,800,000   $ 20,000,000.0    
Other liabilities                
Received lease payments   4,400,000   4,400,000        
Cannabis cultivation and processing facility, California                
Maximum construction loan agreed to lend   23,000,000.0   23,000,000.0        
General and administrative expense                
Office lease expense   $ 100,000 $ 100,000 $ 400,000 $ 400,000      
Building and Improvements                
Estimated useful lives (in years)   40 years   40 years        
Underlying assets gross carrying value   $ 28,900,000   $ 28,900,000        
Office equipment and furniture and fixtures | Minimum                
Estimated useful lives (in years)   3 years   3 years        
Office equipment and furniture and fixtures | Maximum                
Estimated useful lives (in years)   7 years   7 years        
Land                
Underlying assets gross carrying value   $ 4,100,000   $ 4,100,000        
v3.24.3
Summary of Significant Accounting Policies and Procedures and Recent Accounting Pronouncements - Concentration of Credit Risk (Details)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
USD ($)
lease
tenant
property
Sep. 30, 2023
tenant
lease
Sep. 30, 2024
USD ($)
tenant
lease
state
property
Sep. 30, 2023
tenant
lease
Dec. 31, 2023
property
Concentration Risk          
Number of properties | property 108   108    
Number of states in which properties are owned | state     19    
Number of tenants | tenant 30   30    
Number of properties for which possession regained | property         2
Maximum          
Concentration Risk          
Cash FDIC insured limits | $ $ 250,000   $ 250,000    
Non cannabis tenants          
Concentration Risk          
Number of tenants excluded from lease | tenant     3    
Number of properties excluded from lease | property     2    
Rental revenues (including tenant reimbursements) | Customer concentration          
Concentration Risk          
Number of tenants | tenant 5 5 5 5  
Rental revenues (including tenant reimbursements) | Customer concentration | PharmaCann          
Concentration Risk          
Number of Leases 11 11 11 11  
Percentage of concentration risk 17.00% 15.00% 17.00% 15.00%  
Rental revenues (including tenant reimbursements) | Customer concentration | Ascend Wellness Holdings, Inc.          
Concentration Risk          
Number of Leases 4 4 4 4  
Percentage of concentration risk 11.00% 10.00% 11.00% 10.00%  
Rental revenues (including tenant reimbursements) | Customer concentration | Holistic Industries Inc.          
Concentration Risk          
Number of Leases     5    
Percentage of concentration risk     8.00%    
Rental revenues (including tenant reimbursements) | Customer concentration | Green Thumb Industries, Inc.          
Concentration Risk          
Number of Leases 3 3 3 3  
Percentage of concentration risk 8.00% 8.00% 8.00% 8.00%  
Rental revenues (including tenant reimbursements) | Customer concentration | Curaleaf Holdings, Inc.          
Concentration Risk          
Number of Leases 8 8 8 8  
Percentage of concentration risk 7.00% 7.00% 7.00% 7.00%  
Rental revenues (including tenant reimbursements) | Customer concentration | SH Parent, Inc. ("Parallel")          
Concentration Risk          
Number of Leases       4  
Percentage of concentration risk       7.00%  
Rental revenues (including tenant reimbursements) | Customer concentration | Trulieve Cannabis Corp.          
Concentration Risk          
Number of Leases 6 6      
Percentage of concentration risk 7.00% 7.00%      
Net real estate held for investment | Geographic Concentration Risk          
Concentration Risk          
Concentration risk     5.00%   5.00%
Net real estate held for investment | Geographic Concentration Risk | New York          
Concentration Risk          
Percentage of concentration risk     5.50%    
Concentration risk         5.40%
v3.24.3
Common Stock (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 9 Months Ended 12 Months Ended
May 31, 2024
item
$ / shares
shares
Sep. 30, 2024
USD ($)
$ / shares
shares
Sep. 30, 2023
USD ($)
shares
Dec. 31, 2023
$ / shares
shares
Common stock, shares authorized   50,000,000   50,000,000
Common stock, par value (in dollars per share) | $ / shares   $ 0.001   $ 0.001
Common stock, shares issued   28,331,833   28,140,891
Common stock, shares outstanding   28,331,833   28,140,891
Preferred stock, Par Value (in dollars per share) | $ / shares   $ 0.001   $ 0.001
Net proceeds from issuance | $   $ 11,757    
Number of shares issued upon conversion   28,408 32,200  
Exchangeable Senior Notes, rate   3.75%    
Outstanding principal amount | $   $ 4,300 $ 2,000  
Prior ATM Program        
Net proceeds from issuance | $   $ 11,800    
Number of shares issued   123,224 0  
At The Market Offerings        
Number of sales agents | item 4      
Series A Preferred Stock        
Preferred Stock, Dividend Rate, Percentage   9.00%   9.00%
Series A Preferred Stock | Prior ATM Program        
Number of shares issued   402,673    
Series A Preferred Stock | At The Market Offerings        
Preferred Stock, Dividend Rate, Percentage 9.00%      
Preferred stock, Par Value (in dollars per share) | $ / shares $ 0.001      
Maximum number of common stock issuable 500,000,000.0      
v3.24.3
Preferred Stock (Details) - USD ($)
$ / shares in Units, $ in Thousands
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Preferred Stock, Shares Authorized 50,000,000   50,000,000
Preferred stock, Par Value (in dollars per share) $ 0.001   $ 0.001
Issuance of Series A Preferred Stock, net of offering costs $ 9,623    
Prior ATM Program      
Net proceeds from sale of common stock (in shares) 123,224 0  
Series A Preferred Stock      
Preferred Stock, Shares Issued 1,002,673   600,000
Preferred Stock, Shares Outstanding 1,002,673   600,000
Preferred Stock, Redemption Price Per Share $ 25.00    
Preferred Stock, Voting Rights Holders of the Series A Preferred Stock generally have no voting rights except for limited voting rights if the Company fails to pay dividends for six or more quarterly periods (whether or not consecutive) and in certain other circumstances.    
Series A Preferred Stock | Prior ATM Program      
Net proceeds from sale of common stock (in shares) 402,673    
Issuance of Series A Preferred Stock, net of offering costs $ 9,600    
v3.24.3
Dividends (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dividend amount - Series A preferred stock $ 564     $ 338 $ 1,240 $ 1,014
O 2024 Q1 Dividends            
Dividends declared per common share     $ 1.82      
Dividends declared per Series A preferred stock     $ 0.5625      
Dividend amount - Common stock     $ 51,957      
Dividend amount - Series A preferred stock     $ 338      
O 2024 Q2 Dividends            
Dividends declared per common share   $ 1.90        
Dividends declared per Series A preferred stock   $ 0.5625        
Dividend amount - Common stock   $ 54,253        
Dividend amount - Series A preferred stock   $ 338        
O 2024 Q3 Dividends            
Dividends declared per common share $ 1.90          
Dividends declared per Series A preferred stock $ 0.5625          
Dividend amount - Common stock $ 54,253          
Dividend amount - Series A preferred stock $ 564          
Common Stock | O 2024 Q1 Dividends            
Declaration Date     Mar. 15, 2024      
Dividend Paid Date     Apr. 15, 2024      
Common Stock | O 2024 Q2 Dividends            
Declaration Date   Jun. 14, 2024        
Dividend Paid Date   Jul. 15, 2024        
Common Stock | O 2024 Q3 Dividends            
Declaration Date Sep. 13, 2024          
Dividend Paid Date Oct. 15, 2024          
Series A Preferred Stock | O 2024 Q1 Dividends            
Declaration Date     Mar. 15, 2024      
Dividend Paid Date     Apr. 15, 2024      
Series A Preferred Stock | O 2024 Q2 Dividends            
Declaration Date   Jun. 14, 2024        
Dividend Paid Date   Jul. 15, 2024        
Series A Preferred Stock | O 2024 Q3 Dividends            
Declaration Date Sep. 13, 2024          
Dividend Paid Date Oct. 15, 2024          
v3.24.3
Investments in Real Estate (Details)
$ in Thousands
9 Months Ended
Sep. 30, 2024
USD ($)
ft²
Jun. 30, 2004
USD ($)
Rentable Square Feet | ft² 145,000  
Purchase Price $ 13,000  
Transaction Costs 26  
Total $ 13,026  
Land    
Total   $ 2,100
Building and Improvements    
Total   $ 10,900
Ocala    
Rentable Square Feet | ft² 145,000  
Purchase Price $ 13,000  
Transaction Costs 26  
Total 13,026  
Ocala | Maximum    
Agreed funding for redevelopment of building $ 30,000  
v3.24.3
Investments in Real Estate - Intangible assets and related accumulated amortization (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Investments in Real Estate    
Total $ 7,600 $ 8,245
Acquired In-Place Lease Intangible Assets    
Investments in Real Estate    
Gross 9,979 9,979
Accumulated amortization (2,379) (1,734)
Total 7,600 8,245
Above-Market Lease    
Investments in Real Estate    
Gross 1,054 1,054
Accumulated amortization (256) (187)
Total $ 798 $ 867
v3.24.3
Investments in Real Estate - Estimated annual amortization (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity    
Total $ 7,600 $ 8,245
Acquired In-Place Lease Intangible Assets    
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity    
2024 (three months ending December 31) 215  
2025 860  
2026 860  
2027 860  
2028 860  
Thereafter 3,945  
Total $ 7,600 $ 8,245
v3.24.3
Investments in Real Estate - Additional Information (Details)
1 Months Ended 3 Months Ended 9 Months Ended
May 31, 2024
USD ($)
Apr. 30, 2024
USD ($)
property
Feb. 29, 2024
USD ($)
property
Mar. 31, 2023
USD ($)
property
item
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Jan. 31, 2024
property
Real estate property cost         $ 45,000,000.0   $ 45,000,000.0    
Tenant improvements and construction activities funded         45,600,000   45,600,000    
Disposition-contingent lease termination fee             3,900,000    
loss on sale of real estate             3,400,000    
Accrued interest         2,400,000   2,400,000    
4Front Ventures Corp.                  
Number of leased properties | property                 4
Michigan Properties                  
Number of leased properties | property                 1
Illinois properties | 4Front Ventures Corp.                  
Number of leased properties | property   1              
Increase amount of tenant improvement allowance   $ 1,600,000              
Property in Los Angeles, California                  
Contracted sale price of properties disposed $ 9,100,000                
Lease termination fee $ 3,900,000                
Acquired In-Place Lease Intangible Assets                  
Amortization expense         200,000 $ 200,000 $ 600,000 $ 600,000  
Weighted-average amortization period (in years)             9 years    
Above-Market Lease                  
Amortization expense         $ 23,000 $ 23,000 $ 69,000 $ 69,000  
Amortization period (in years)         8 years 8 months 12 days   8 years 8 months 12 days    
PharmaCann | New York Properties                  
Number of leased properties | property     1            
Medical Investor Holdings LLC | California Property                  
Number of properties sold | property       4          
Contracted sale price of properties disposed       $ 16,200,000          
Real estate loans receivable       $ 16,100,000          
Number of options to extend | item       2          
Extension term       12 months          
Minimum principal balance payment       $ 500,000          
Accumulated depreciation         $ 1,900,000   $ 1,900,000    
Medical Investor Holdings LLC | Land | California Property                  
Gross carrying value         3,400,000   3,400,000    
Medical Investor Holdings LLC | Building and Improvements | California Property                  
Gross carrying value         $ 13,900,000   $ 13,900,000    
PharmaCann At New York                  
Increase in construction funding     $ 16,000,000.0            
Battle Green Holdings LLC | Ohio properties                  
Number of leased properties | property   1              
Increase amount of tenant improvement allowance   $ 4,500,000              
v3.24.3
Investments in Real Estate - Future Contractual Minimum Rent (Details)
$ in Thousands
Sep. 30, 2024
USD ($)
Contractual Minimum Rent  
2024 (three months ending December 31) $ 74,500
2025 310,800
2026 322,415
2027 330,720
2028 338,062
Thereafter 3,978,962
Total $ 5,355,459
v3.24.3
Debt - Exchangeable Senior Notes - Additional Information (Details) - USD ($)
1 Months Ended 9 Months Ended
Feb. 29, 2024
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Number of shares issued upon conversion   28,408 32,200  
Outstanding principal amount   $ 4,300,000 $ 2,000,000.0  
Principal amount   300,000,000    
Gain on exchange of debt     22,000  
Principal amount paid   4,436,000    
Additional Paid-In-Capital        
Stock Issued During Period, Value, Conversion of Convertible Securities     $ 2,000,000.0  
Exchangeable Senior Notes        
Number of shares issued upon conversion     32,200  
Outstanding principal amount     $ 2,000,000.0  
Principal amount       $ 4,436,000
Principal amount paid off at maturity   $ 4,300,000    
Principal amount paid $ 100,000      
Exchangeable Senior Notes | Accounts payable and accrued expenses        
Accrued interest payable       $ 49,000
Exchangeable Senior Notes | Common Stock        
Conversion of Stock, Shares Issued   28,408    
Principal amount paid   $ 4,300,000    
v3.24.3
Debt - Exchangeable Senior Notes - Interest expense (Details) - Exchangeable Senior Notes - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Cash coupon $ 41 $ 24 $ 140
Amortization of issuance cost 9 5 29
Capitalized interest (2) (1) (2)
Total interest expense $ 48 $ 28 $ 167
v3.24.3
Debt - Exchangeable Senior Notes - Carrying value (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Principal amount $ 300,000  
Exchangeable Senior Notes    
Principal amount   $ 4,436
Unamortized issuance cost   (5)
Carrying value   $ 4,431
v3.24.3
Debt - Notes due 2026 (Details) - USD ($)
$ in Thousands
9 Months Ended
May 25, 2021
Sep. 30, 2024
Dec. 31, 2023
Principal amount   $ 300,000  
Notes due 2026      
Principal amount $ 300,000 $ 300,000 $ 300,000
Interest rate 5.50%    
Issuance costs $ 6,800    
Debt Instrument, Interest Rate, Effective Percentage   6.03%  
Notes due 2026 | Minimum      
Debt instrument change in debt rating interest rate 6.00%    
Notes due 2026 | Maximum      
Debt instrument change in debt rating interest rate 6.50%    
Notes due 2026 | Redeemed Prior To February 25, 2026      
Percentage of principal amount redeemed   100.00%  
Notes due 2026 | Redeemed On Or After February 25, 2026      
Percentage of principal amount redeemed   100.00%  
Notes due 2026 | Accounts payable and accrued expenses      
Accrued interest payable   $ 6,200 $ 2,100
v3.24.3
Debt - Notes due 2026 - Interest expense (Details) - Notes due 2026 - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Cash coupon $ 4,125 $ 4,125 $ 12,375 $ 12,375
Amortization of issuance cost 357 335 1,054 992
Capitalized interest (127) (178) (516) (212)
Total interest expense $ 4,355 $ 4,282 $ 12,913 $ 13,155
v3.24.3
Debt - Notes due 2026 - Carrying value (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
May 25, 2021
Principal amount $ 300,000    
Notes due 2026      
Principal amount 300,000 $ 300,000 $ 300,000
Unamortized issuance cost (2,497) (3,551)  
Carrying value $ 297,503 $ 296,449  
v3.24.3
Debt - Revolving Credit Facility (Details) - Revolving Credit Facility - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2024
Oct. 31, 2023
Aggregate commitments     $ 50,000,000.0
Loan amount outstanding $ 0 $ 0  
Issuance costs 800,000 800,000  
Non-cash interest expense $ 72,000 $ 200,000  
v3.24.3
Debt - Principal Payments (Details)
$ in Thousands
Sep. 30, 2024
USD ($)
Debt  
2026 $ 300,000
Total $ 300,000
v3.24.3
Net Income Per Share - Additional information (Details) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dilutive effect of Exchangeable Senior Notes   75,682 12,647 83,007
PSUs        
Dilutive effect of share-based payment arrangements 25,352   25,352  
v3.24.3
Net Income Per Share - Computations of net income per basic and diluted share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Net income $ 40,215 $ 41,594 $ 121,636 $ 123,955
Preferred stock dividends (564) (338) (1,240) (1,014)
Distribution to participating securities (570) (372) (1,684) (1,106)
Net income attributable to common stockholders used to compute net income per share - basic 39,081 40,884 118,712 121,835
Dilutive effect of Exchangeable Senior Notes   50 28 169
Net income attributable to common stockholders used to compute net income per share - diluted $ 39,081 $ 40,934 $ 118,740 $ 122,004
Weighted-average common shares outstanding:        
Basic 28,254,565 27,983,004 28,216,946 27,971,544
Dilutive effect of Exchangeable Senior Notes   75,682 12,647 83,007
Diluted 28,579,687 28,265,605 28,548,050 28,248,054
Net income attributable to common stockholders per share:        
Basic (in dollars per share) $ 1.38 $ 1.46 $ 4.21 $ 4.36
Diluted (in dollars per share) $ 1.37 $ 1.45 $ 4.16 $ 4.32
Restricted stock and RSUs        
Weighted-average common shares outstanding:        
Dilutive effect of share-based payment arrangements 299,770 206,919 293,105 193,503
PSUs        
Weighted-average common shares outstanding:        
Dilutive effect of share-based payment arrangements 25,352   25,352  
v3.24.3
Fair Value of Financial Instruments (Details)
$ in Thousands
Sep. 30, 2024
USD ($)
Dec. 31, 2023
USD ($)
Investments, Carrying Value $ 25,315 $ 21,948
Investments as cash equivalents, Carrying Value 55,104 15,187
Exchangeable Senior Notes, Carrying Value   4,431
Notes due 2026, Carrying Value 297,503 296,449
Construction Loan receivable 22,000 22,000
Notes receivable, Carry Value 16,796 20,028
Investments, Fair Value 25,318 21,951
Investments as cash equivalents, Fair Value 54,996 15,029
Exchangeable Senior Notes, Fair Value   7,576
Notes due 2026, Fair Value 292,389 278,325
Construction Loan, Fair Value 27,844 27,543
Notes receivable, Fair Value $ 16,796 $ 20,028
Expected market yield    
Loan Receivable, Measurement Input 0.1625 0.1625
Weighted average expected market yield    
Notes Receivable, Measurement Input 0.197 0.172
v3.24.3
Common Stock Incentive Plan - Additional Information (Details) - USD ($)
$ in Millions
1 Months Ended 3 Months Ended 9 Months Ended
Jan. 31, 2022
Jan. 31, 2021
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Restricted Stock                
Unrecognized compensation cost     $ 5.2       $ 5.2  
Amortization period             1 year 9 months 18 days  
Fair value of restricted stock             $ 2.6  
Granted     0 3,186 43,566      
RSUs                
Unrecognized compensation cost     $ 8.0       $ 8.0  
Amortization period             1 year 9 months 18 days  
Granted     0 2,832 69,714      
PSUs                
Amortization period             3 months 18 days  
Granted 102,641 70,795            
Stock-based compensation expense     $ 1.7     $ 2.7 $ 5.0 $ 8.0
Remaining unrecognized compensation     $ 1.7       $ 1.7  
2016 Plan                
Expiration term             10 years  
2016 Plan | Maximum                
Number of shares authorized     1,000,000       1,000,000  
v3.24.3
Common Stock Incentive Plan - Activity (Details) - $ / shares
3 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Restricted Stock      
Common Stock Incentive Plan      
Shares, Beginning Balance 77,268 79,137 56,711
Granted 0 3,186 43,566
Vested   (5,055) (13,698)
Forfeited     (7,442)
Shares, Ending Balance 77,268 77,268 79,137
Weighted-Average Grant Date Fair Value, Beginning Balance $ 108.95 $ 106.37 $ 135.46
Weighted-Average Grant Date Fair Value, Granted   113.05 91.81
Weighted-Average Grant Date Fair Value, Vested   71.23 126.83
Weighted-Average Grant Date Fair Value, Forfeited     205.15
Weighted-Average Grant Date Fair Value, Ending Balance $ 108.95 $ 108.95 $ 106.37
Restricted Stock Units      
Common Stock Incentive Plan      
Shares, Beginning Balance 222,502 219,670 149,956
Granted 0 2,832 69,714
Shares, Ending Balance 222,502 222,502 219,670
Weighted-Average Grant Date Fair Value, Beginning Balance $ 114.68 $ 114.70 $ 125.34
Weighted-Average Grant Date Fair Value, Granted   113.05 91.81
Weighted-Average Grant Date Fair Value, Ending Balance $ 114.68 $ 114.68 $ 114.70
v3.24.3
Commitments and Contingencies (Details)
$ in Thousands
Sep. 30, 2024
USD ($)
Commitments and Contingencies  
2024 (three months ending December 31) $ 128
2025 526
2026 543
2027 45
Total future contractual lease payments 1,242
Effect of discounting (83)
Office lease liability $ 1,159
Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration] Other Liabilities
v3.24.3
Commitments and Contingencies - Additional Information (Details)
Sep. 30, 2024
USD ($)
Amended Class Action Lawsuit  
Commitments and Contingencies  
Amount accrued $ 0
Derivative Action Lawsuit  
Commitments and Contingencies  
Amount accrued 0
Commitments related to improvement allowances  
Commitments and Contingencies  
Other Commitment 44,200,000
Commitments related to construction commitments  
Commitments and Contingencies  
Other Commitment 1,100,000
Commitments related to construction loan  
Commitments and Contingencies  
Other Commitment $ 1,000,000.0
v3.24.3
Subsequent Events (Details)
$ in Millions
1 Months Ended
Oct. 31, 2024
USD ($)
ft²
Nov. 30, 2024
USD ($)
Oct. 31, 2023
USD ($)
Revolving Facility      
Subsequent Events      
Revolving credit facility maximum     $ 50.0
Subsequent Event | Industrial property, Maryland      
Subsequent Events      
Net rentable area of the property acquired | ft² 23,000    
Payments for area of property acquired $ 5.6    
Subsequent Event | Revolving Facility      
Subsequent Events      
Revolving credit facility maximum $ 50.0 $ 87.5